Archive for March, 2012

Spire (SPIR) Completes Sale of Semiconductor Business For Aggregate Consideration of $8.5 Million

Spire Corporation (“Spire”) (NASDAQ: SPIR), a diversified global company providing solar photovoltaic equipment and systems, and biomedical processing services, announced today that it has completed the sale of substantially all the assets of Spire Semiconductor, LLC’s foundry services business for aggregate consideration of $8.5 million, as described in more detail below, to Masimo Semiconductor, Inc., a wholly owned subsidiary of Masimo Corporation (“Masimo”).

“With the divestiture of our semiconductor business to Masimo, Spire has strengthened its financial position and can now more aggressively pursue opportunities in its solar and biomedical businesses,” said Roger G. Little, Chairman and Chief Executive Officer of Spire Corporation. “For the past several years, Masimo has been one of our largest customers and is an ideal strategic buyer for the business.”

Joe Kiani, Masimo CEO and Chairman of the Board stated, “Spire Semiconductor is a very innovative company. We have been extremely impressed with their technology and the service they have provided to us as a customer. We plan to continue building on the proprietary technology base established by Spire Semiconductor. The acquisition will permit us to focus the operation on Masimo’s custom component requirements and accelerate technology advancements in our non-invasive blood monitoring products.”

The asset purchase agreement provided that the aggregate purchase price for the Semiconductor Business unit was $8.0 million plus the assumption of $500,000 in liabilities, with the cash portion of the purchase price being reduced by retained cash and liabilities assumed by Masimo in excess of $500,000. As a result on the closing date, the Company received approximately $7.2 million in cash and Masimo assumed approximately $1.2 million in liabilities. Of the purchase price approximately 10% of the cash portion was deposited into an indemnity escrow account for fifteen months.

ThinkEquity LLC served as exclusive financial adviser to Spire Corporation.

About Spire Corporation

Spire Corporation is a diversified company serving the solar energy, biomedical and defense industries worldwide with innovative products and services based upon a common technology platform. For further details on the Company and its products, please visit www.spirecorp.com.

Certain matters described in this press release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on market growth, competition and dependence on government agencies and other third parties for funding contract research and services, as well as other factors described in the Company’s Form 10-K and other periodic reports filed with the Securities and Exchange Commission.

Monday, March 12th, 2012 Uncategorized Comments Off on Spire (SPIR) Completes Sale of Semiconductor Business For Aggregate Consideration of $8.5 Million

FuelCell Energy (FCEL) and POSCO Energy Announce Expanded Partnership

DANBURY, Conn., March 12, 2012 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq:FCEL) a leading manufacturer of ultra-clean, efficient and reliable fuel cell power plants, today announced the signing of Memorandums of Understanding (MOU) outlining a series of strategic initiatives with its South Korean partner, POSCO Energy (formally POSCO Power). These include a 120 megawatt (MW) multi-year order commitment, acceleration of deliveries under the existing 70 MW order, and a license commitment which provides for the manufacturing of Direct FuelCell® (DFC®) components in South Korea by October 2014.

“We are experiencing increasing demand for ultra-clean baseload fuel cell power plants from electric utilities and independent power producers under the South Korean Renewable Portfolio Standard and we are projecting significant demand from the commercial building market in South Korea as well as exports to other Asian countries,” said Soung-Sik Cho, President and CEO, POSCO Energy. “We are investing in increased capacity to meet this forecasted demand as the capacity of the existing FuelCell Energy production facility in the USA is not sufficient to meet our mutual global demand forecasts.”

Under the terms of the MOU, POSCO Energy will purchase 20,000,000 shares of FCEL common stock at a price of $1.50 per share for proceeds of $30 million. Proceeds will be used for general corporate purposes. The transaction is expected to close in April 2012.

“This strategic transaction reflects significant progress for FuelCell Energy and our ultra-clean stationary fuel cell power plants as we execute on our global growth plans, strengthen our balance sheet and drive to profitability,” said Chip Bottone, President and Chief Executive Officer for FuelCell Energy, Inc. “This announcement will be welcomed by project investors as it expands the global manufacturing footprint for our Direct FuelCell products.”

The MOU anticipates that POSCO Energy will order 120 MW of fuel cell kits for delivery starting in 2013 and concluding in 2016, all to be produced at the Torrington, Connecticut production facility owned by FuelCell Energy. Additionally, the MOU contemplates that the existing 70 MW order will be accelerated from 2.8 MW of fuel cell kits delivered each month to 4.2 MW per month, beginning in August 2012.

“The 120 megawatt order provides a committed level of production for our Torrington Connecticut production facility for the next several years, which provides certainty to our supply chain and increases capacity utilization,” continued Mr. Bottone.

The expanded license agreement will provide for the manufacture of Direct FuelCell components in Korea in a facility owned by POSCO Energy. POSCO Energy will provide the land and building in Pohang, South Korea for the manufacturing facility along with all necessary funding for construction and daily operation of the facility. POSCO Energy will pay a one-time licensing fee upon execution of the agreement and an on-going royalty. The expanded license agreement is expected to be finalized in the Company’s third quarter of 2012.

DFC power plants efficiently provide ultra-clean and reliable power at the point of use. The fuel cells utilize an electrochemical process to efficiently generate ultra-clean electricity and usable high quality heat. Due to the absence of combustion, virtually no pollutants are emitted. Avoiding the emission of NOx, SOx and particulate matter supports clean air regulations and benefits public health. The high efficiency of the fuel cell power generation process reduces fuel costs and carbon emissions, and producing both electricity and heat from the same unit of fuel further supports favorable economics while also promoting sustainability. Fuel cells can achieve up to 90 percent efficiency when configured to use the high quality heat generated by the power plant in a combined heat & power (CHP) mode.

FuelCell Energy management will discuss these strategic initiatives as part of the previously scheduled First Quarter 2012 earnings call at 10:00 am Eastern Time on March 12, 2012. The live webcast of the call will be available on the Company website at www.fuelcellenergy.com. To listen to the call, select ‘Investors’ on the home page, then click on ‘events & presentations’ and then click on ‘Listen to the webcast.’

About FuelCell Energy

Direct FuelCell® power plants are generating ultra-clean, efficient and reliable power at more than 50 locations worldwide. With over 180 megawatts of power generation capacity installed or in backlog, FuelCell Energy is a global leader in providing ultra-clean baseload distributed generation to utilities, industrial operations, universities, municipal water treatment facilities, government installations and other customers around the world. The Company’s power plants have generated more than one billion kilowatt hours of ultra-clean power using a variety of fuels including renewable biogas from wastewater treatment and food processing, as well as clean natural gas. For more information please visit our website at www.fuelcellenergy.com

The FuelCell Energy, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3284

This news release contains forward-looking statements, including statements regarding the Company’s plans and expectations regarding the continuing development, commercialization and financing of its fuel cell technology and business plans. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could cause such a difference include, without limitation, whether the Company is able to reach definitive agreements on the terms contemplated in the recently announced memorandums of understanding with POSCO Energy, general risks associated with product development, manufacturing, changes in the regulatory environment, customer strategies, potential volatility of energy prices, rapid technological change, competition, and the Company’s ability to achieve its sales plans and cost reduction targets, as well as other risks set forth in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements contained herein speak only as of the date of this press release. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in the Company’s expectations or any change in events, conditions or circumstances on which any such statement is based.

Direct FuelCell, DFC, DFC/T, DFC-H2 and FuelCell Energy, Inc. are all registered trademarks of FuelCell Energy, Inc. DFC-ERG is a registered trademark jointly owned by Enbridge, Inc. and FuelCell Energy, Inc.

CONTACT: FuelCell Energy, Inc.
         Kurt Goddard, Vice President Investor Relations
         203-830-7494
         ir@fce.com

Donna R. Ferenz

Monday, March 12th, 2012 Uncategorized Comments Off on FuelCell Energy (FCEL) and POSCO Energy Announce Expanded Partnership

Clean Diesel Technologies, Inc. (CDTI) Reports Fourth Quarter and Fiscal Year 2011 Financial Results

VENTURA, Calif., March 12, 2012 /PRNewswire/ — Clean Diesel Technologies, Inc. (NASDAQ: CDTI) (“Clean Diesel”), a cleantech emissions reduction company, announced today its financial results for the fourth quarter and fiscal year ended December 31, 2011. The highlights are as follows:

  • Record fourth quarter revenue of $21.3 million, up 80.5% year over year
  • Income from operations of $0.2 million in fourth quarter 2011 compared to loss from operations of $3.9 million in 2010
  • Record fiscal year 2011 revenue of $61.6 million, up 28.0% year over year

“Fourth quarter revenue exceeded our expectations, recording growth of over 80%,” said Craig Breese, Chief Executive Officer of Clean Diesel. “Sales in our Heavy Duty Diesel Systems division more than doubled compared to the prior year quarter. This was led by strong sales, both in the London Low Emission Zone (“LEZ”) and the North America retrofit market. Meanwhile, external sales for our Catalyst division grew more than 17% compared to the prior-year quarter.

“Our 27.6% gross margin was a significant improvement over the 23.2% recorded in the fourth quarter of 2010. For the year, gross margins increased by 350 basis points compared to 2010. This gross margin improvement was attributable in large part to a substantial increase in intercompany catalyst sales.

“We are very pleased with the strong finish of 2011. Sales in the London LEZ represented $8.0 million for the year and $6.0 million in the fourth quarter. Given the extension announced by the regulator in December, we expect an additional $3.0 million to $4.0 million of sales in the first quarter of 2012. In addition, with the California Truck and Bus Regulation going into effect this year, we believe the mandatory emissions compliance of over 150,000 Class 7 and 8 Heavy Duty trucks over the next 3 years provides us with a unique opportunity to grow the business in 2012 and beyond.”

Financial Results

Fourth Quarter 2011

The October 15, 2010 business combination with Catalytic Solutions, Inc. (or “CSI”), which Clean Diesel refers to as the “Merger” was accounted for as a reverse acquisition. Accordingly, Clean Diesel’s (the legal acquirer’s) consolidated financial statements are now those of CSI (the accounting acquirer), with the assets and liabilities and revenues and expenses of legacy Clean Diesel being included in CSI’s financial statements effective from October 15, 2010, the closing date of the Merger. As such, the amounts discussed below for periods prior to the Merger are those of CSI and its consolidated subsidiaries, with amounts of legacy Clean Diesel operations included from the date of the Merger.

Total revenue for the fourth quarter of 2011 was $21.3 million, an increase of $9.5 million, or 80.5%, from $11.8 million for the prior year quarter. Total revenue from legacy Clean Diesel business as a result of the Merger, includes $0.4 million, unchanged from the prior year quarter, all of which is included in Clean Diesel’s Heavy Duty Diesel Systems division.

Revenue for Clean Diesel’s Heavy Duty Diesel Systems division for the quarter ended December 31, 2011 increased $8.9 million, or 105.9%, to $17.3 million from $8.4 million for the prior year quarter. Revenue, excluding intercompany sales, for Clean Diesel’s Catalyst division for the quarter ended December 31, 2011 increased $0.6 million, or 17.3%, to $4.0 million from $3.4 million for the prior year quarter. Intercompany sales to its Heavy Duty Diesel Systems division increased by $2.4 million for the quarter ended December 31, 2011 compared to the prior year quarter.

Total operating expenses for the fourth quarter of 2011 were $5.7 million, compared to $6.6 million in the prior year quarter.

Net income for the fourth quarter of 2011 was $0.5 million, or $0.06 per diluted share, compared to net loss of $5.6 million, or $1.71 per share, in the prior year quarter. Net income included non-cash expense of approximately $0.1 million related to stock based compensation expense and $0.5 million related to depreciation and amortization of intangible assets, including those acquired in the Merger, for a total of approximately $0.6 million compared to $0.1 million and $0.4 million, respectively, for a total of approximately $0.5 million in the net loss for the same period in 2010. Diluted common shares outstanding were 7,217,000 in the current quarter compared to 3,280,000 in the same quarter a year ago, with the increase in the number of shares due principally to the public offering completed on July 5, 2011.

At December 31, 2011 and December 31, 2010, Clean Diesel had cash and cash equivalents of $3.5 million and $5.0 million, respectively. As previously announced, Clean Diesel completed a public offering on July 5, 2011 in which Clean Diesel sold 3,053,750 shares of common stock resulting in net proceeds of $10.2 million after deducting underwriting commissions and expenses. On October 7, 2011, Clean Diesel entered into a purchase agreement with Lincoln Park Capital Fund, LLC (“LPC”) which provides Clean Diesel with the option, at its sole discretion, to sell to LPC up to $10.0 million of its common stock. Currently, 1,823,577 shares have been registered with the Securities and Exchange Commission for this purpose. Net proceeds from the public offering and any net proceeds resulting from sales of stock under the purchase agreement are intended to be used for working capital and general corporate purposes.

Full Year 2011

Total revenue for the year ended December 31, 2011 was $61.6 million, an increase of $13.5 million, or 28.0%, from $48.1 million for the prior year. Total revenue includes $2.2 million from legacy Clean Diesel business as a result of the Merger, all of which is included in Clean Diesel’s Heavy Duty Diesel Systems division.

Revenue for Clean Diesel’s Heavy Duty Diesel Systems division for the year ended December 31, 2011 increased $16.2 million, or 52.3%, to $47.4 million from $31.2 million for the prior year. Revenue, excluding intercompany sales, for Clean Diesel’s Catalyst division for the year ended December 31, 2011 was down $2.7 million, or 16.6%, to $14.2 million from $16.9 million for the prior year. Intercompany sales to its Heavy Duty Diesel Systems division increased $5.8 million for the year ended December 31, 2011 compared to the same period in 2010.

Total operating expenses for the year ended December 31, 2011 were $24.1 million, compared to $15.8 million for the prior year. Total operating expenses for the prior year included a $3.9 million gain, which arose from the sale of specific three-way catalyst technology and intellectual property to Clean Diesel’s partner in its Asian investment.

Net loss for the year ended December 31, 2011 was $7.3 million, or $1.31 per share, compared to a net loss of $8.3 million, or $6.71 per share, in the prior year. Net loss included non-cash expense of approximately $1.5 million related to stock based compensation expense and $1.7 million related to depreciation and amortization of intangible assets, including those acquired in the Merger, for a total of approximately $3.2 million compared to approximately $0.3 million and $1.3 million, respectively, for a total of approximately $1.6 million in the same period in 2010. Diluted common shares outstanding were 5,574,000 for the year ended December 31, 2011 compared to 1,238,000 for the prior year, with the increase in the number of shares due principally to the public offering completed on July 5, 2011.

Mr. Breese concluded, “I am pleased to be taking over as Chief Executive Officer following the significant positive momentum from 2011. We expect this momentum to continue into the first quarter of 2012. In 2012, we anticipate good growth in our Heavy Duty Diesel Systems business compared to 2011 as sales in the London LEZ conclude and as key retrofit programs are implemented in North America, particularly in California. We also expect to see more stable demand from our OEM customers for light duty vehicle catalysts. We realize the world continues to face economic uncertainty and risk, so a critical part of our planning process is to make sure we’re prepared for a potentially more challenging situation. In 2011, we strengthened our balance sheet through a successful completion of a public offering in early July and establishing a discretionary equity commitment from Lincoln Park Capital in October. As of today we have not needed to utilize this equity commitment, but it does provide us with the flexibility we may need to fund the growth of our business. Overall, we are encouraged by our performance in 2011 and look forward to delivering solid results in 2012.”

Conference Call and Webcast Information

Clean Diesel will host a conference call and simultaneous webcast over the Internet beginning at 12:00 p.m. Pacific Time today to discuss its financial results and its business outlook. This conference call will contain forward-looking information. To participate in the conference call, dial +1 (877) 303-9240 and use confirmation code 58405818. International participants should dial +1 (760) 666-3571 and use the same confirmation code. The conference call will be webcast live on the Clean Diesel website at www.cdti.com under the “Investor Relations” section. To listen to the live webcast, participants should visit the site at least 15 minutes prior to the conference to download any required streaming media software. An archived recording of the conference call will be available on the Clean Diesel website for 30 days.

About Clean Diesel Technologies, Inc.

Clean Diesel is a vertically integrated global manufacturer and distributor of emissions control systems and products, focused on the heavy duty diesel and light duty vehicle markets. Clean Diesel utilizes its proprietary patented Mixed Phase Catalyst (MPC®) technology, as well as its ARIS® selective catalytic reduction, Platinum Plus® fuel-borne catalyst, and other technologies to provide high-value sustainable solutions to reduce emissions, increase energy efficiency and lower the carbon intensity of on- and off-road engine applications. Clean Diesel is headquartered in Ventura, California and currently has operations in the U.S., Canada, U.K., France, Japan and Sweden. For more information, please visit www.cdti.com.

Forward-Looking Statements Safe Harbor

Certain statements in this news release, such as statements regarding Clean Diesel’s estimated sales in the London LEZ and increased sales by its Heavy Duty Diesel Systems division, overall business growth and momentum, implementation of government mandated diesel retrofit programs and the stabilized demand from OEM customers for its catalyst products constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known or unknown risks, including those detailed in Clean Diesel’s filings with the U.S. Securities and Exchange Commission, uncertainties and other factors that may cause the actual results, performance or achievements of Clean Diesel to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Clean Diesel assumes no obligation to update the forward-looking information contained in this release.

Clean Diesel Technologies, Inc.

Summary Income Statements (unaudited)

($ millions)

3 Months Ended

December 31,

Year Ended

December 31,

2011

2010

2011

2010

Revenues

$

21.3

$

11.8

$

61.6

$

48.1

Gross profit

5.9

2.7

17.6

12.0

Gross margin

27.6%

23.2%

28.5%

25.0%

Operating expenses:

Selling, general and administrative

3.7

3.4

16.7

11.8

Research and development

2.0

1.2

7.4

4.4

Recapitalization expense

1.8

3.2

Severance Expense

0.2

0.3

Gain on sale of intellectual property

(3.9)

Total operating expenses

$

5.7

$

6.6

$

24.1

$

15.8

Income (loss) from operations

$

0.2

$

(3.9)

$

(6.5)

$

(3.8)

Other expense

(0.5)

(2.6)

(0.4)

(5.5)

Loss from continuing operations before income tax

(0.3)

(6.5)

(6.9)

(9.3)

Income tax (benefit) expense from continuing operations

(0.7)

(0.5)

0.3

Net income (loss) from continuing operations

0.4

(6.0)

(7.2)

(9.3)

Discontinued operations

0.1

0.4

(0.1)

1.0

Net income (loss)

$

0.5

$

(5.6)

$

(7.3)

$

(8.3)

Basic and diluted EPS

$

0.06

$

(1.71)

$

(1.31)

$

(6.71)

Weighted shares outstanding (in thousands)

7,217

3,280

5,574

1,238

Clean Diesel Technologies, Inc.

Segment Information

($ millions)

3 Months Ended

December 31,

Year Ended

December 31,

2011

2010

2011

2010

Revenue

Heavy Duty Diesel Systems

$

17.3

$

8.4

$

47.4

$

31.2

Catalyst

6.8

3.8

20.8

17.7

Eliminations

(2.8)

(0.4)

(6.6)

(0.8)

Total

$

21.3

$

11.8

$

61.6

$

48.1

Income (loss) from operations

Heavy Duty Diesel Systems

$

0.3

$

(0.4)

$

1.4

$

2.0

Catalyst

1.1

(1.0)

(1.0)

(2.6)

Corporate

(1.2)

(2.5)

(6.7)

(3.2)

Eliminations

(0.2)

Total

$

0.2

$

(3.9)

$

(6.5)

$

(3.8)

Clean Diesel Technologies, Inc.

Summary Balance Sheets (unaudited)

($ millions)

As of

December 31

2011

2010

Total current assets

$

27.1

$

17.6

Total assets

$

41.1

$

32.7

Total current liabilities

$

15.7

$

14.8

Total long-term liabilities

$

5.5

$

2.6

Stockholders’ equity

$

19.9

$

15.4

Short-term debt

$

4.5

$

2.4

Long-term debt

$

4.5

$

1.5

Monday, March 12th, 2012 Uncategorized Comments Off on Clean Diesel Technologies, Inc. (CDTI) Reports Fourth Quarter and Fiscal Year 2011 Financial Results

NewLead Holdings Ltd. (NEWL) Announces Progress in the Restructuring Process

PIRAEUS, Greece, March 12, 2012 /PRNewswire/ — NewLead Holdings Ltd. (NASDAQ: NEWL) (“NewLead” or the “Company”), an international shipping company owning and operating tankers and dry bulk vessels, today announced the completion of the sale of the four LR1 product tankers and one Panamax dry bulk vessel, the 1990-built “Newlead Esmeralda”. The sale of these vessels was conducted as part of the Company’s overall financial restructuring plan.

Following the successful completion of sale of the five vessels, the net sales proceeds have been applied in full satisfaction of all liabilities under the governing loan agreements. NewLead’s overall indebtedness decreased by an aggregate of approximately $159.0 million after these sales, of which a decrease of $147.9 million resulted from the sale of the four LR1 product tankers and a decrease of $11.1 million resulted from the sale of the “Newlead Esmeralda” for total sale proceeds of $12.0 million out of which $0.9 million will be used to satisfy a substantial part of the vessel’s trade debt.

Michael Zolotas, President and Chief Executive Officer of NewLead, stated, “The successful completion of the sale of the five vessels is a momentous step forward in achieving a successful restructuring for the Company. We have significantly reduced the indebtedness of the Company and together with our restructuring advisors continue to work with our lenders to successfully complete the financial restructuring of NewLead and move the Company forward.”

About NewLead Holdings Ltd.

NewLead Holdings Ltd. is an international, vertically integrated shipping company that owns and manages product tankers and dry bulk vessels. NewLead currently controls 11 vessels, of which two are double-hull product tankers and 9 are dry bulk vessels including four newbuildings and one vessel currently under construction that is scheduled to be delivered in the third quarter of 2012. NewLead’s common shares are traded under the symbol “NEWL” on the NASDAQ Global Select Market. To learn more about NewLead Holdings Ltd., please visit the new website at www.newleadholdings.com

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995

This press release includes assumptions, expectations, projections, intentions and beliefs about future events. These statements, as well as words such as “anticipate,” “estimate,” “project,” “plan,” and “expect,” are intended to be ”forward-looking” statements. We caution that assumptions, expectations, projections, intentions and beliefs about future events may vary from actual results and the differences can be material. Forward-looking statements include, but are not limited to, such matters as future operating or financial results; our liquidity position and cash flows, our ability to borrow additional amounts under our revolving credit facility and, if needed, to obtain waivers from our lenders and restructure our debt, and our ability to continue as a going concern; statements about planned, pending or recent vessel disposals and/or acquisitions, business strategy, future dividend payments and expected capital spending or operating expenses, including dry-docking and insurance costs; statements about trends in the product tanker and dry bulk vessel shipping segments, including charter rates and factors affecting supply and demand; expectations regarding the availability of vessel acquisitions; completion of repairs; length of off-hire; availability of charters; and anticipated developments with respect to any pending litigation. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although NewLead believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, NewLead cannot assure you that it will achieve or accomplish these expectations, beliefs or projections described in the forward looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including changes in charter rates and vessel values, failure of a seller to deliver one or more vessels, and other factors discussed in NewLead’s filings with the U.S. Securities and Exchange Commission from time to time. NewLead expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in NewLead’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Investor and Media Relations:
Elisa Gerouki
NewLead Holdings Ltd.
Telephone: + 30 213 014 8023
Email: egerouki@newleadholdings.com

Monday, March 12th, 2012 Uncategorized Comments Off on NewLead Holdings Ltd. (NEWL) Announces Progress in the Restructuring Process

Harris Interactive (HPOL) Announces Share Repurchase Program; Provides Current Fiscal Year Guidance

NEW YORK, March 8, 2012 /PRNewswire/ — Harris Interactive Inc. (NASDAQ: HPOL), a global market research firm, today announced that its Board of Directors has authorized a share repurchase program of up to $3 million of the Company’s common stock over the next twenty-four months. The program calls for the repurchases to be made at management’s discretion in the open market or through privately negotiated transactions from time to time in compliance with applicable laws, rules, and regulations, subject to cash requirements for other purposes, and other relevant factors, such as trading price, trading volume, general market and business conditions, Company performance, and the Company’s compliance with the covenants under its credit agreement.

(Logo: http://photos.prnewswire.com/prnh/20100518/NY06801LOGO )

The share repurchase authorization does not obligate the Company to acquire any specific number of shares in any period, and may be modified, suspended, or discontinued at any time at the discretion of the Company’s Board of Directors. Share repurchases will be funded using cash generated from operations, and repurchased shares will be retired and returned to unissued status.

Commenting on the share repurchase program announcement, Al Angrisani, President and Chief Executive Officer of Harris Interactive, said, “Although we still have a lot of work to do to successfully execute the turnaround program, I am pleased with the progress we have made to date. The share repurchase program allows the Company flexibility to repurchase shares at its discretion while maintaining sufficient liquidity, and reflects our commitment to returning value to our stockholders.”

Eric Narowski, Interim Chief Financal Officer of Harris Interactive, further commented, “Based on current market conditions and forecasts, the Company projects Adjusted EBITDA after the effect of restructuring and other charges to be between $9.5 and $11.5 million for the fiscal year ending June 30, 2012. At the mid-range of this guidance, fiscal 2012 Adjusted EBITDA after the effect of restructuring and other charges is projected to increase approximately 54% compared with fiscal 2011. Relative to our projected fiscal 2012 performance, we believe that our stock is currently undervalued and view the repurchase program as an efficient way to enhance stockholder value.”

Cautionary Note Regarding Forward Looking Statements

Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, among others, statements as to future economic performance, projections as to financial items, estimates, and plans and objectives for future operations, products and services. In some cases, you can identify forward-looking statements by terminology such as, “may”, “should”, “expects”, “plans”, “anticipates”, “feel”, “believes”, “estimates”, “predicts”, “potential”, “continue”, “consider”, “possibility”, or the negative of these terms or other comparable terminology. These forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward looking statements. Such risks and uncertainties include, without limitation, risks detailed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K, as updated quarterly in our Quarterly Reports on Form 10-Q to reflect additional material risks. The Company has filed its reports on Forms 10-K and 10-Q with the Securities and Exchange Commission, and they are available under the Investor Relations section of our website at http://ir.harrisinteractive.com/. Risks and uncertainties also include the continued volatility of the global macroeconomic environment and its impact on the Company and its clients, the Company’s ability to sustain and grow its revenue base, the Company’s ability to maintain and improve cost efficient operations, the impact of reorganization, restructuring and related charges, quarterly variations in financial results, actions of competitors, the Company’s ability to develop and maintain products and services attractive to the market, the Company’s ability to remain in compliance with the financial covenants in its credit agreement, and uncertainties surrounding the Company’s ability to regain compliance with certain NASDAQ listing requirements.

You are urged to consider these factors carefully in evaluating such forward-looking statements and are cautioned not to place undue reliance on them. The forward-looking statements are qualified in their entirety by this cautionary statement.

Non-GAAP Financial Measure

Included in this press release is Adjusted EBITDA, which is a “non-GAAP financial measure”. This non-GAAP financial measure should not be considered in isolation; it is in addition to, and is not a substitution, for financial performance measures under GAAP. This non-GAAP financial measure may be different from non-GAAP measures used by other companies. Further, we may utilize other measures to illustrate performance in the future. Non-GAAP measures have limitations since they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP. The Company has disclosed the reconciliation between EBITDA and Adjusted EBITDA and GAAP net income (loss) below to compensate for these limitations.

The Company defines Non-GAAP Adjusted EBITDA as earnings before net interest expense, income taxes, depreciation and amortization, and stock based compensation. Non-GAAP Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. The Company is presenting Non-GAAP Adjusted EBITDA because it provides investors with an additional way to view its operations, when considered with both its GAAP results and the reconciliation to net income, which the Company believes provides a more complete understanding of its business than could be obtained absent this disclosure. Non-GAAP Adjusted EBITDA is presented solely as a supplemental disclosure because: (i) the Company believes it is a useful tool for investors to assess the operating performance of the business without the effect of non-cash depreciation, amortization and stock based compensation expenses; (ii) the Company believes that investors will find this data useful in assessing its ability to service or incur indebtedness; and (iii) Non-GAAP Adjusted EBITDA is a component of the financial covenant measures used by the Company’s lenders in connection with the Company’s credit facilities. The use of Non-GAAP Adjusted EBITDA has limitations and should not be considered in isolation from or as an alternative to GAAP measures, such as net income, operating income or other data prepared in accordance with GAAP, or as a measure of the Company’s profitability or liquidity.

The Company believes that its description of Non-GAAP Adjusted EBITDA after the effect of restructuring and other charges is useful to investors because it provides a means for investors to better understand the Company’s ongoing operations.

About Harris Interactive
Harris Interactive is one of the world’s leading custom market research firms, leveraging research, technology, and business acumen to transform relevant insight into actionable foresight. Known widely for the Harris Poll and for pioneering innovative research methodologies, Harris offers expertise in a wide range of industries including health care, technology, public affairs, energy, telecommunications, financial services, insurance, media, retail, restaurant, and consumer package goods. Serving clients in more than 215 countries and territories through our North American and European offices and a network of independent market research firms, Harris specializes in delivering research solutions that help us – and our clients – stay ahead of what’s next. For more information, please visit www.harrisinteractive.com.

HPOL – F

Reconciliation of GAAP Loss to EBITDA and Adjusted EBITDA (1)

Amounts in millions of USD

For the Fiscal Year
Ending June 30,
2012 (2)(3)

For the Fiscal
Year Ended
June 30, 2011

GAAP net loss

$ (4.8)

$ (8.5)

Loss from discontinued operations, net of tax

2.0

0.8

Interest expense, net

0.7

1.2

Provision for income taxes

0.1

0.2

Depreciation and amortization

5.9

7.3

EBITDA

$ 3.9

$ 1.0

Stock-based compensation (4)

1.2

0.7

Adjusted EBITDA

$ 5.1

$ 1.7

Adjusted EBITDA

$ 5.1

$ 1.7

Add-back of restructuring and other charges

5.4

5.1

Adjusted EBITDA with add-back of restructuring and other charges

$ 10.5

$ 6.8

(1) Results shown above reflect the reclassification of our Asian operations as discontinued operations for all periods shown.

(2) This reconciliation is based on the midpoint of the Adjusted EBITDA guidance range provided in this press release.

(3) The amounts expressed in this column are based on current estimates as of the date of this press release.

(4) Stock-based compensation expense represents the cost of stock-based compensation awarded by the Company to its employees under the FASB guidance for stock-based compensation.

Press Contact:
Michael T. Burns
Investor Relations
Harris Interactive Inc.
800-866-7655 x7328
mburns@harrisinteractive.com

Thursday, March 8th, 2012 Uncategorized Comments Off on Harris Interactive (HPOL) Announces Share Repurchase Program; Provides Current Fiscal Year Guidance

Intellicheck Mobilisa (IDN) Announces 2011 Fourth Quarter and Year End Financial Results

Intellicheck Mobilisa (NYSE Amex: IDN) has released its financial results for the fourth quarter and year ended December 31, 2011.

Revenues for the quarter ended December 31, 2011 decreased 6% to $2,868,031 compared to $3,046,567 in the same period of the previous year. Adjusted EBITDA was $283,835 for the fourth quarter of 2011 compared to $(253,795) for the fourth quarter of 2010. Net loss for the three months ended December 31, 2011 was $13,907 or $(0.00) per diluted share compared to a net loss of $641,844 or $(0.02) per diluted share for the three months ended December 31, 2010. The Company’s backlog, which represents non-cancelable sales orders for products not yet shipped and services to be performed, was approximately $2.8 million at December 31, 2011, compared to $2.8 million at December 31, 2010.

For the year ended December 31, 2011, revenues increased 2% to $12,484,331 compared to revenues of $12,291,551 reported in the same period of the prior year. Adjusted EBITDA for 2011 increased to $875,164 compared to $(938,934) in 2010. Net loss was $290,859 or $(0.01) per diluted share for the year ended December 31, 2011, compared to a net loss of $2,573,223 or $(0.10) for the year ended December 31, 2010.

Steve Williams, CEO of Intellicheck Mobilisa, commented, “Our efforts to reduce costs are reflected in our numbers and we intend to place additional resources on growing our revenues during 2012.”

Q4 2011 and Recent Highlights:

  • Commercial Identity Group enters into contract with major international banking firm to incorporate ID Check into the teller transaction system
  • ACCOR’s Motel 6 and Studio 6 hotels integrate ScanINN™ check-in and ID verification software with their property management system

Conference Call Information

IDN will host a conference call for members of the investment community today at 1:00 p.m. Eastern / 10:00 a.m. Pacific Time. Interested parties dial (877) 407-8037 approximately 10 minutes before the scheduled beginning. To listen to the conference call, please dial (877) 407-8037. For callers outside the U.S., please dial (201) 689-8037. The slides may be viewed at: http://www.investorcalendar.com/IC/CEPage.asp?ID=167126 and will also be available on our website: www.icmobil.com under Investor Relations. For those unable to participate in the live conference, a recording will be available for 48 hours after the call. The rebroadcast can be accessed by dialing (877) 660-6853 and (201) 612-7415 for international callers. The account access code is 327 and the replay ID is 387178. After the 48-hour window, please visit the investor relations portion of our website at http://www.icmobil.com for rebroadcast.

About Intellicheck Mobilisa

Intellicheck Mobilisa (ICMOBIL) is a leading technology company that is engaged in developing and marketing wireless technology and identity systems for various applications, including mobile and handheld access control and security systems for the government, military and commercial markets. ICMOBIL’s products include the Fugitive Finder system, an advanced ID card access control product currently protecting approximately 100 military and federal locations; ID-Check, a patented technology that instantly reads, analyzes, and verifies encoded data in magnetic stripes and barcodes on government-issued IDs from U.S. and Canadian jurisdictions, designed to improve the Customer Experience for the financial, hospitality and retail sectors; and Aegeus, a wireless security buoy system for the government, military and oil industry.

For more news and information on ICMOBIL, please visit www.icmobil.com.

Safe Harbor Statement

Certain statements in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. When used in this press release, words such as “will,” “believe,” “expect,” “anticipate,” “encouraged,” and similar expressions, as they relate to the company or its management, as well as assumptions made by and information currently available to the company’s management identify forward-looking statements. Actual results may differ materially from the information presented here. Additional information concerning forward-looking statements is contained under the heading of risk factors listed from time to time in the company’s filings with the SEC. We do not assume any obligation to update the forward-looking information.

Adjusted EBITDA

Intellicheck Mobilisa uses Adjusted EBITDA as a non-GAAP financial performance measurement. Adjusted EBITDA is calculated by adding back to net income (loss) interest, income taxes, impairments of long-lived assets and goodwill, depreciation, amortization and stock-based compensation expense. Adjusted EBITDA is provided to investors to supplement the results of operations reported in accordance with GAAP. Management believes that Adjusted EBITDA provides an additional tool for investors to use in comparing Intellicheck Mobilisa financial results with other companies that also use Adjusted EBITDA in their communications to investors. By excluding non-cash charges such as impairments of long-lived assets and goodwill, amortization, depreciation and stock-based compensation, as well as non-operating charges for interest and income taxes, investors can evaluate the Company’s operations and can compare its results on a more consistent basis to the results of other companies. In addition, adjusted EBITDA is one of the primary measures management uses to monitor and evaluate financial and operating results.

Intellicheck Mobilisa considers Adjusted EBITDA to be an important indicator of the Company’s operational strength and performance of its business and a useful measure of the Company’s historical operating trends. However, there are significant limitations to the use of Adjusted EBITDA since it excludes interest income and expense, impairments of long lived assets and goodwill, stock based compensation expense, all of which impact the Company’s profitability, as well as depreciation and amortization related to the use of long term assets which benefit multiple periods. Intellicheck Mobilisa believes that these limitations are compensated by providing Adjusted EBITDA only with GAAP net income (loss) and clearly identifying the difference between the two measures. Consequently, Adjusted EBITDA should not be considered in isolation or as a substitute for net income (loss) presented in accordance with GAAP. Adjusted EBITDA as defined by the Company may not be comparable with similarly named measures provided by other entities. A reconciliation of Adjusted EBITDA to GAAP net income or loss is included in the enclosed schedule.

INTELLICHECK MOBILISA, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended Year Ended
December 31, December 31,
(Unaudited)
2011 2010 2011 2010
REVENUES $ 2,868,031 $ 3,046,567 $ 12,484,331 $ 12,291,551
COST OF REVENUES (927,466 ) (1,043,260 ) (4,339,772 ) (4,297,158 )
Gross profit 1,940,565 2,003,307 8,144,559 7,994,393
OPERATING EXPENSES
Selling 430,569 687,922 1,896,747 2,380,979
General and administrative 872,418 1,212,492 3,922,024 5,181,005
Research and development 651,488 742,248 2,608,020 2,979,047
Total operating expenses 1,954,475 2,642,662 8,426,791 10,541,031
Loss from operations (13,910 ) (639,355 ) (282,232 ) (2,546,638 )
OTHER INCOME (EXPENSE)
Interest income 3 11 40 87
Interest expense (2,500 ) (8,667 ) (24,808 )
Other expense (1,864 )
3 (2,489 ) (8,627 ) (26,585 )
Loss before income taxes (13,907 ) (641,844 ) (290,859 ) (2,573,223 )
Provision for income taxes
Net loss $ (13,907 ) $ (641,844 ) $ (290,859 ) $ (2,573,223 )
PER SHARE INFORMATION
Net loss per common share –
Basic and diluted $ ( 0.00 ) $ (0.02 ) $ (0.01 ) $ (0.10 )
Weighted average common shares used in
computing per share amounts –
Basic and diluted 27,462,504 26,990,708 27,247,558 26,645,897
CONDENSED CONSOLIDATED BALANCE SHEETS
ASSETS
December 31, December 31,
2011 2010
CURRENT ASSETS:
Cash and cash equivalents $ 1,394,148 $ 1,488,904
Accounts receivable, net of allowance of $4,884 and $1,651
as of December 31, 2011 and 2010, respectively 3,058,788 2,905,794
Inventory 11,894 17,524
Other current assets 108,770 115,195
Total current assets 4,573,600 4,527,417
PROPERTY AND EQUIPMENT, net 439,736 570,613
GOODWILL 12,308,661 12,308,661
INTANGIBLE ASSETS, net 5,551,149 6,494,134
OTHER ASSETS 72,006 73,051
Total assets $ 22,945,152 $ 23,973,876
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable $ 221,019 $ 366,924
Accrued expenses 675,907 858,058
Deferred revenue, current portion 1,692,881 1,935,144
Notes payable 193,333
Total current liabilities 2,589,807 3,353,459
OTHER LIABILITIES
Deferred revenue, long-term portion 405,190 709,378
Deferred rent 194,759 125,426
Total liabilities 3,189,756 4,188,263
STOCKHOLDERS’ EQUITY 19,755,396 19,785,613
Total liabilities and stockholders’ equity $ 22,945,152 $ 23,973,876
RECONCILIATION OF ADJUSTED EBITDA TO NET LOSS
(Unaudited)
Three Months Ended Year Ended
December 31, December 31,
2011 2010 2011 2010
Net loss $ (13,907 ) $ (641,844 ) $ (290,859 ) $ (2,573,223 )
Reconciling items:
Interest – net (3 ) 2,489 8,627 24,721
Provision for income taxes
Depreciation and amortization 275,855 283,878 1,123,509 1,135,743
Stock-based compensation 21,890 101,682 33,887 473,825
Adjusted EBITDA $ 283,835 $ (253,795 ) $ 875,164 $ (938,934 )
Thursday, March 8th, 2012 Uncategorized Comments Off on Intellicheck Mobilisa (IDN) Announces 2011 Fourth Quarter and Year End Financial Results

MTR Gaming Group (MNTG) Reports Fourth Quarter 2011 Results

MTR Gaming Group, Inc. (NasdaqGS: MNTG) today announced financial results for the fourth quarter and full year ended December 31, 2011.

Fourth Quarter 2011 Highlights and Subsequent Events

  • Net revenue growth of 9.3%, including net revenue growth of 15.2% for Mountaineer Casino, Racetrack & Resort
  • Record Adjusted EBITDA from continuing operations of $20.0 million
  • Adjusted EBITDA margin of 19.3%, a 110 basis point increase from the prior-year quarter
  • In January 2012, Scioto Downs Casino & Racetrack received its conditional gaming license to install and operate video lottery terminals, and construction is progressing on schedule at the facility

“We are pleased with our fourth quarter 2011 results, which saw a considerable increase in revenue, record Adjusted EBITDA and improved Adjusted EBITDA margin, which was the result of our focus on targeted marketing programs at our facilities, optimizing our cost structure, improving economic conditions in the region and favorable weather in the latter part of the fourth quarter,” said Jeffrey J. Dahl, President and Chief Executive Officer of MTR Gaming Group, Inc. “Looking forward into 2012, we have already received our conditional license to install and operate video lottery terminals (“VLTs”) at our Scioto Downs Casino & Racetrack and are pleased to note that construction is proceeding on schedule for an anticipated second quarter 2012 opening. Once completed, we believe the casino will have a significant beneficial impact on the Columbus, Ohio area in terms of entertainment, job opportunities and economic growth, as well as provide long-term value for our stockholders.”

For the fourth quarter of 2011, the Company’s total net revenues were $103.6 million, an increase of 9.3% compared to $94.8 million in the same period of 2010. Adjusted EBITDA from continuing operations was $20.0 million, up 15.9% compared to $17.2 million in the fourth quarter of 2010. The fourth quarter 2011 Adjusted EBITDA margin was 19.3% compared to 18.2% in the prior-year quarter.

The Company reported a net loss of $6.0 million for the quarter, or $0.21 per diluted share (which included income of $0.8 million from discontinued operations), compared to a net loss of $2.8 million, or $0.10 per diluted share, in the same period of 2010, due primarily to increased interest expense associated with the Company’s debt refinancing in the third quarter of 2011.

Net revenues at Mountaineer Casino, Racetrack & Resort increased 15.2% to $55.8 million in the fourth quarter of 2011 compared to $48.4 million in the fourth quarter of 2010. Revenues from slots were $41.9 million compared to $36.4 million in the same quarter of 2010, while table gaming at Mountaineer generated $7.2 million of revenues compared to $6.1 million in the prior-year period. The property saw Adjusted EBITDA increase to $11.7 million from $9.0 million in the comparable quarter of 2010. The Adjusted EBITDA margin at Mountaineer increased to 21.0% compared to 18.6% in the prior-year quarter. As previously mentioned, the increase in net revenues and Adjusted EBITDA was attributable to targeted marketing programs and operating efficiencies at Mountaineer, as well as improving economic conditions and milder winter weather in the latter part of 2011.

Net revenues at Presque Isle Downs & Casino increased 3.2% to $47.5 million during the fourth quarter of 2011 compared to $46.0 million during the fourth quarter of 2010. Table gaming at Presque Isle Downs generated $5.4 million of revenues compared to $4.7 million in the prior-year period, while slot revenue increased by $0.8 million compared to the same quarter of 2010. The property generated Adjusted EBITDA of $10.9 million compared to $10.4 million in the same quarter of 2010, with the Adjusted EBITDA margin increasing to 23.0% compared to 22.6% in the prior-year period. The increase in net revenues and Adjusted EBITDA for the fourth quarter of 2011 was primarily attributable to the milder winter weather and operating efficiencies.

Corporate overhead costs increased by 21% to $2.3 million during the fourth quarter of 2011 compared to $1.9 million in the prior-year period, due primarily to increases in compensation-related expenses.

Full Year 2011 Highlights

For the year ended December 31, 2011, MTR’s total net revenues increased approximately 1% to $428.1 million compared to $424.9 million in the prior year. Adjusted EBITDA from continuing operations increased 6.7% to $82.6 million (which includes $2.1 million received from a mineral rights lease bonus payment) from $77.4 million last year (which includes $1.4 million of project-opening costs and $1.7 million of severance costs). For the year ended December 31, 2011, net loss was $50.4 million, or $1.81 per diluted share, and includes a $34.4 million pre-tax loss on debt extinguishment associated with MTR’s refinancing, a pre-tax charge of $5.9 million representing an estimate of the Company’s obligations associated with its estimated proportionate assessment of amounts due under an Administrative Order executed by the Pennsylvania Gaming Control Board on July 11, 2011 and other related assessments, income tax expense of approximately $4.0 million attributable to an increase in the valuation allowance on deferred tax assets and $0.8 million in income from discontinued operations. Absent these charges and discontinued operations, the net loss would have been $6.9 million, or $0.25 per diluted share. In the same period last year, the Company reported net loss of $5.1 million, or $0.19 per diluted share, which included a loss of $0.2 million from discontinued operations.

See attached tables, including reconciliation of income (loss) from continuing operations and income (loss) from discontinued operations, GAAP financial measures, to Adjusted EBITDA, as well as the calculation of Adjusted EBITDA margin, non-GAAP financial measures.

Balance Sheet and Liquidity

As of December 31, 2011, MTR had $85.6 million in cash and cash equivalents, $130.1 million of funds that are held for construction of the video lottery terminal gaming facility at Scioto Downs Casino & Racetrack, and $548.9 million in total debt, net of discount. In addition, the Company has $20 million available for borrowing under its revolving credit facility.

Reconciliation of GAAP Measures to Non-GAAP Measures

Adjusted EBITDA represents earnings (losses) before interest, income taxes, depreciation and amortization, gain (loss) on the sale or disposal of property, loss on asset impairment, loss on debt modification and extinguishment, other regulatory gaming assessment costs and equity in loss of unconsolidated joint venture, to the extent that such items existed in the periods presented. Adjusted EBITDA margin represents the calculation of Adjusted EBITDA divided by net revenues. Adjusted EBITDA and Adjusted EBITDA margin are not measures of performance or liquidity calculated in accordance with generally accepted accounting principles (“GAAP”), are unaudited and should not be considered as an alternative to, or more meaningful than, net income (loss) or income (loss) from operations or operating margin as indicators of our operating performance, or cash flows from operating activities, as a measure of liquidity. Adjusted EBITDA and Adjusted EBITDA margin have been presented as supplemental disclosures because they are widely used measures of performance and basis’ for valuation of companies in our industry. Management of the Company uses Adjusted EBITDA and Adjusted EBITDA margin as primary measures of the Company’s operating performance and as components in evaluating the performance of operating personnel. Uses of cash flows that are not reflected in Adjusted EBITDA include capital expenditures, interest payments, income taxes, debt principal repayments, and certain regulatory gaming assessments which can be significant. Moreover, other companies that provide EBITDA and/or Adjusted EBITDA information may calculate EBITDA and/or Adjusted EBITDA differently than we do. A reconciliation of GAAP income (loss) from continuing operations and GAAP income (loss) from discontinued operations to Adjusted EBITDA, as well as the calculation of Adjusted EBITDA margin, is included in the financial tables accompanying this release.

Conference Call

Management will conduct a conference call focusing on the financial results and corporate developments today at 4:30 p.m. EST. Interested parties may participate in the call by dialing (888) 713-3595. Please call in 10 minutes before the call is scheduled to begin and ask for the MTR Gaming call (conference ID #3987455).

The conference call will be webcast live via the Investor Relations section of the Company’s website at www.mtrgaming.com. To listen to the live webcast please go to the website at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen to the live call, the conference call will be archived on the Investor Relations section of the Company’s website.

A replay of the call will be available two hours following the end of the call through midnight EDT on Thursday, March 15, 2012 at www.mtrgaming.com and by telephone at (877) 870-5176; passcode 3987455.

About MTR Gaming Group

MTR Gaming Group, Inc. is a hospitality and gaming company that through subsidiaries owns and operates Mountaineer Casino, Racetrack & Resort in Chester, West Virginia; Presque Isle Downs & Casino in Erie, Pennsylvania; and Scioto Downs Casino & Racetrack in Columbus, Ohio. For more information, please visit www.mtrgaming.com.

Forward-Looking Statements

Except for historical information, this press release contains forward-looking statements concerning, among other things the prospects for improving the results of our operations at Mountaineer, Presque Isle Downs and Scioto Downs, including the success and growth of table gaming at Presque Isle Downs and Mountaineer and the successful implementation of video lottery terminals at Scioto Downs. Such statements are subject to a number of risks and uncertainties that could cause the statements made to be incorrect and/or for actual results to differ materially. Those risks and uncertainties include, but are not limited to, the impact of new competition for Mountaineer and Presque Isle Downs (including casino gaming and video lottery terminals in Ohio), the establishment of video lottery terminals at Scioto Downs, pending the receipt of required regulatory approval, the effectiveness of our marketing programs, the enactment of future gaming legislation in the jurisdictions in which we operate (including the implementation of casino gaming in Cleveland and Columbus, Ohio and the implementation of video lottery terminals at racetracks in Ohio), changes in, or failure to comply with, laws, regulations or the conditions of our gaming licenses, accounting standards or environmental laws, including adverse changes in the gaming tax rates that the Company currently pays in its various jurisdictions, general economic conditions, disruption (occasioned by weather conditions or work stoppages) of our operations, our ability to improve our operating margins, our continued suitability to hold and obtain renewals of our gaming and racing licenses, our ability to fulfill our obligations and comply with the covenants associated with our various debt instruments and/or our ability to obtain additional debt and/or equity financing, if and when needed, and other factors described in the Company’s periodic reports filed with the Securities and Exchange Commission. The Company does not intend to update publicly any forward-looking statements, except as may be required by law. The cautionary advice in this paragraph is permitted by the Private Securities Litigation Reform Act of 1995.

MTR GAMING GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(dollars in thousands, except per share amounts)
Three Months Ended Year Ended
December 31 December 31
2011 2010 2011 2010
(unaudited) (unaudited)
Revenues:
Gaming $ 94,122 $ 85,986 $ 385,300 $ 382,514
Pari-mutuel commissions 1,929 2,117 10,206 11,181
Food, beverage and lodging 7,881 7,056 32,617 32,265
Other 2,609 1,961 11,058 8,737
Total revenues 106,541 97,120 439,181 434,697
Less promotional allowances (2,951 ) (2,357 ) (11,095 ) (9,806 )
Net revenues 103,590 94,763 428,086 424,891
Operating expenses:
Expenses of operating departments:
Gaming:
Operating costs 58,266 53,933 238,343 238,594
Other regulatory assessments 167 5,925 800
Pari-mutuel commissions 2,252 2,126 11,411 11,276
Food, beverage and lodging 5,670 5,227 23,701 23,249
Other 1,468 1,321 6,271 6,144
Marketing and promotions 2,931 2,801 12,609 12,788
General and administrative 12,992 12,114 52,963 54,068
Project opening costs 36 197 1,365
Depreciation 6,863 7,162 27,939 28,733
Impairment loss 685 685 40
Loss on the sale or disposal of property 682 30 470 75
Total operating expenses 92,012 84,714 380,514 377,132
Operating income 11,578 10,049 47,572 47,759
Other income (expense):
Interest income 75 15 145 37
Interest expense (17,162 ) (13,383 ) (60,159 ) (54,120 )
Loss on debt extinguishment (34,364 )
Loss from continuing operations before income taxes (5,509 ) (3,319 ) (46,806 ) (6,324 )
(Provision) benefit for income taxes (1,256 ) 529 (4,347 ) 1,361
Loss from continuing operations (6,765 ) (2,790 ) (51,153 ) (4,963 )
Discontinued operations:
Income (loss) from discontinued operations before income taxes and non-controlling interest 787 (41 ) 787 (234 )
Benefit for income taxes 14 82
Income (loss) from discontinued operations before non- controlling interest 787 (27 ) 787 (152 )
Non-controlling interest 1 1 (1 )
Income (loss) from discontinued operations 788 (27 ) 788 (153 )
Net loss $ (5,977 ) $ (2,817 ) $ (50,365 ) $ (5,116 )
Net loss per share – basic:
Loss from continuing operations $ (0.24 ) $ (0.10 ) $ (1.84 ) $ (0.18 )
Income (loss) from discontinued operations 0.03 0.03 (0.01 )
Net loss $ (0.21 ) $ (0.10 ) $ (1.81 ) $ (0.19 )
Net loss per share – diluted:
Loss from continuing operations $ (0.24 ) $ (0.10 ) $ (1.84 ) $ (0.18 )
Income (loss) from discontinued operations 0.03 0.03 (0.01 )
Net loss $ (0.21 ) $ (0.10 ) $ (1.81 ) $ (0.19 )
Weighted average number of shares outstanding:
Basic 27,940,702 27,655,526 27,835,649 27,549,546
Diluted 27,940,702 27,655,526 27,835,649 27,549,546
MTR GAMING GROUP, INC.
SELECTED FINANCIAL INFORMATION
(dollars in thousands)
(unaudited)
Three Months Ended Year Ended
December 31 December 31
2011 2010 2011 2010
Net revenues:
Mountaineer Casino, Racetrack & Resort $ 55,766 $ 48,408 $ 224,103 $ 228,784
Presque Isle Downs & Casino 47,505 46,048 201,148 193,005
Scioto Downs 298 285 2,750 2,963
Corporate 21 22 85 139
Consolidated net revenues $ 103,590 $ 94,763 $ 428,086 $ 424,891
Adjusted EBITDA from continuing operations:
Mountaineer Casino, Racetrack & Resort $ 11,718 $ 9,012 $ 47,449 $ 48,451
Presque Isle Downs & Casino 10,949 10,413 45,778 41,047
Scioto Downs (402 ) (300 ) (1,476 ) (1,217 )
Corporate (2,290 ) (1,884 ) (9,160 ) (10,874 )
Consolidated Adjusted EBITDA from continuing operations $ 19,975 $ 17,241 $ 82,591 $ 77,407
Adjusted EBITDA from discontinued operations 626 (41 ) 626 (232 )
Consolidated Adjusted EBITDA $ 20,601 $ 17,200 $ 83,217 $ 77,175
_______________________________________________________________________
The following tables set forth a reconciliation of income (loss) from continuing operations and income (loss) from discontinued operations, GAAP financial measures, to Adjusted EBITDA, as well as the calculation of Adjusted EBITDA margin, non-GAAP financial measures.
_______________________________________________________________________
Three Months Ended Year Ended
December 31 December 31
2011 2010 2011 2010
ADJUSTED EBITDA FROM CONTINUING OPERATIONS:
Mountaineer Casino, Racetrack & Resort:
Income from continuing operations $ 8,732 $ 1,549 $ 35,653 $ 22,526
Interest (income) expense, net (2 ) 9 22 142
Provision (benefit) for income taxes 4,211 (4 ) 12,328
Depreciation 2,786 3,223 11,831 13,383
Impairment loss 204 204
(Gain) loss on the sale or disposal of property (2 ) 20 (257 ) 72
Adjusted EBITDA from continuing operations $ 11,718 $ 9,012 $ 47,449 $ 48,451
Net revenues $ 55,766 $ 48,408 $ 224,103 $ 228,784
Adjusted EBITDA margin 21.0 % 18.6 % 21.2 % 21.2 %
Presque Isle Downs & Casino:
Income from continuing operations $ 4,548 $ 1,431 $ 19,491 $ 15,160
Interest (income) expense, net (3 ) 7 4 28
Provision for income taxes 1,268 5,240 3,927 10,553
Other regulatory gaming assessment 167 5,925 800
Depreciation 3,873 3,725 15,292 14,503
Impairment loss 412 412
Loss on the sale or disposal of property 684 10 727 3
Adjusted EBITDA from continuing operations $ 10,949 $ 10,413 $ 45,778 $ 41,047
Net revenues $ 47,505 $ 46,048 $ 201,148 $ 193,005
Adjusted EBITDA margin 23.0 % 22.6 % 22.8 % 21.3 %
Scioto Downs:
Loss from continuing operations $ (557 ) $ (222 ) $ (2,164 ) $ (1,355 )
(Capitalized interest) interest expense, net (37 ) 16 (20 ) 70
Benefit for income taxes (295 ) (733 )
Depreciation 192 201 767 801
Gain on debt extinguishment (59 )
Adjusted EBITDA from continuing operations $ (402 ) $ (300 ) $ (1,476 ) $ (1,217 )
MTR GAMING GROUP, INC.
SELECTED FINANCIAL INFORMATION (continued)
(dollars in thousands)
(unaudited)
Three Months Ended Year Ended
December 31 December 31
2011 2010 2011 2010
ADJUSTED EBITDA FROM CONTINUING OPERATIONS (continued):
Corporate:
Loss from continuing operations $ (19,488 ) $ (5,548 ) $ (104,133 ) $ (41,294 )
Interest expense, net of interest income 17,129 13,336 60,008 53,843
(Benefit) provision for income taxes (12 ) (9,685 ) 424 (23,509 )
Depreciation 12 13 49 46
Impairment loss 69 69 40
Loss on debt extinguishment 34,423
Adjusted EBITDA from continuing operations $ (2,290 ) $ (1,884 ) $ (9,160 ) $ (10,874 )
Consolidated:
Loss from continuing operations $ (6,765 ) $ (2,790 ) $ (51,153 ) $ (4,963 )
Interest expense, net of interest income and capitalized interest 17,087 13,368 60,014 54,083
Provision (benefit) for income taxes 1,256 (529 ) 4,347 (1,361 )
Other regulatory gaming assessment 167 5,925 800
Depreciation 6,863 7,162 27,939 28,733
Loss on the sale or disposal of property 682 30 470 75
Impairment loss 685 685 40
Loss on debt extinguishment 34,364
Adjusted EBITDA from continuing operations $ 19,975 $ 17,241 $ 82,591 $ 77,407
Net revenues $ 103,590 $ 94,763 $ 428,086 $ 424,891
Adjusted EBITDA margin 19.3 % 18.2 % 19.3 % 18.2 %
ADJUSTED EBITDA FROM DISCONTINUED OPERATIONS:
Income (loss) from discontinued operations $ 788 $ (27 ) $ 788 $ (153 )
Interest (income) expense (162 ) (162 ) 3
(Benefit) provision for income taxes (14 ) (82 )
Adjusted EBITDA from discontinued operations $ 626 $ (41 ) $ 626 $ (232 )
MTR GAMING GROUP, INC.
CONSOLIDATED BALANCE SHEETS
(dollars in thousands)
December 31 December 31
2011 2010
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 85,585 $ 53,820
Restricted cash 1,146 1,143
Accounts receivable, net of allowance for doubtful accounts of $383 in 2011 and $386 in 2010 4,554 2,790
Amounts due from West Virginia Lottery Commission 122
Inventories 3,503 3,476
Deferred financing costs 1,622 4,106
Deferred income taxes 494
Prepaid expenses and other current assets 5,366 5,177
Total current assets 102,392 70,512
Property and equipment, net 299,579 314,484
Funds held for construction project 130,114
Goodwill 494
Other intangibles 85,577 85,529
Deferred financing costs, net of current portion 9,919 8,113
Deposits and other 1,902 1,984
Non-operating real property 11,207 12,215
Assets of discontinued operations 181 178
Total assets $ 640,871 $ 493,509
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 1,461 $ 1,887
Accounts payable – gaming taxes and assessments 8,854 7,968
Accrued payroll and payroll taxes 4,114 3,861
Accrued interest 27,072 16,702
Accrued income taxes 958 546
Other accrued liabilities 10,741 9,052
Construction project and equipment liabilities 3,732 136
Deferred income taxes 64
Current portion of long-term debt and capital lease obligations 1,255
Liabilities of discontinued operations 223 217
Total current liabilities 57,155 41,688
Long-term debt and capital lease obligations, net of current portion 548,933 376,830
Other regulatory gaming assessments 5,408
Deferred income taxes 11,048 6,756
Total liabilities 622,544 425,274
Stockholders’ equity:
Common stock
Additional paid-in capital 62,804 61,910
(Accumulated Deficit) retained earnings (44,288) 6,359
Accumulated other comprehensive loss (404) (251)
Total stockholders’ equity of MTR Gaming Group, Inc. 18,112 68,018
Non-controlling interest of discontinued operations 215 217
Total stockholders’ equity 18,327 68,235
Total liabilities and stockholders’ equity $ 640,871 $ 493,509
Thursday, March 8th, 2012 Uncategorized Comments Off on MTR Gaming Group (MNTG) Reports Fourth Quarter 2011 Results

Sequenom (SQNM) Announces Participation at the Barclays Global Healthcare Conference

SAN DIEGO, Calif., March 8, 2012 /PRNewswire/ — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company’s participation at the Barclays Global Healthcare Conference at the Loews Miami Hotel in Miami, FL on March 13-14, 2012.

Ronald M. Lindsay, Ph.D., Director and EVP of Research and Development, will present on Wednesday, March 14, 2012 beginning at 4:15 p.m. ET, to provide an overview of and update on the Company. The presentation is expected to last approximately 30 minutes and will be web cast live through the “Investors” section of the Sequenom website at www.sequenom.com. An audio replay will be available for 30 days following the initial presentation web cast.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

SOURCE Sequenom, Inc.

Thursday, March 8th, 2012 Uncategorized Comments Off on Sequenom (SQNM) Announces Participation at the Barclays Global Healthcare Conference

GSE Systems (GVP) Announces 2011 Fourth Quarter and Full Year Financial Results

GSE Systems, Inc. (“GSE” or “the Company”) (NYSE Amex: GVP), a global energy services solutions provider, announced financial results for the fourth quarter and year ended December 31, 2011.

Jim Eberle, Chief Executive Officer of GSE, commented, “2011 was an important and eventful year for GSE: we increased revenue, improved our margins significantly, operated profitably, and made notable progress towards diversifying our revenue streams and broadening our portfolio of energy services solutions.

“During 2011, we closed the acquisition of GSE EnVision, introduced a suite of new products, commercialized our 3D Visualization business, made strategic hires, and completed a reorganization designed to focus our energies and provide a firm foundation for growth. In 2011, we were awarded contracts totaling $44.4 million, $16.1 million of which were awarded in Q4 2011. Thus far in Q1 2012, we have announced $8.0 million in new contracts. All of these awards address a variety of energy end markets, including nuclear, fossil, process simulation, 3D Visualization, training, and engineering services. GSE’s business development activities and organic growth initiatives align with our core operating thesis that as energy demand continues to rise, the looming shortage of qualified energy operations professionals – many of whom are at or near retirement age – remains a growing industry concern.”

Mr. Eberle continued, “Our financial position at December 31, 2011 included cash and cash equivalents of $20.3 million, or $1.09 per diluted share, working capital of $30.2 million, and $0 in long-term debt.”

Q4 2011 RESULTS

Q4 2011 revenue was $15.0 million, up 21.7% from $12.3 million in Q4 2010, reflecting a change in scope to an ongoing simulation project and a $0.9 million revenue contribution from GSE EnVision Inc., which was acquired in January 2011.

Gross profit in Q4 2011 rose to $4.5 million, or 30.0% of revenue, from $1.9 million, or 15.7% of revenue, in Q4 2010. A significant portion of the improvement is attributable to the fact that in Q4 2010, the Company had a large negative adjustment due to the above-mentioned change in project scope and no corresponding adjustment in Q4 2011. Additionally, only 3.9% of total Q4 2011 revenue was comprised of lower margin revenue from the Slovak reactor project as compared to 18.9% of total revenue in Q4 2010. Also contributing to the improved Q4 2011 gross margin was revenue from GSE EnVision, whose products typically generate a substantially higher gross profit margin than the Company’s normal gross profit margin.

Operating income for Q4 2011 increased to $1.3 million from an operating loss of $2.1 million in Q4 2010. The improvement reflects the Q4 2011 higher gross margin and a $1.1 million reduction in selling, general and administrative expenses. The change in the fair value of contingent consideration related to the TAS and EnVision acquisitions resulted in a gain of $0.7 million for Q4 2011 versus a loss of $0.1 million in Q4 2010. In Q4 2010, the Company incurred bad debt expense of $0.2 million.

Net income for Q4 2011 improved to $1.2 million, or $0.06 per basic and diluted share, from a net loss of $2.5 million, or $0.13 per basic and diluted share, in Q4 2010.

Earnings before interest, taxes, depreciation and amortization (“EBITDA”) for Q4 2011 were $1.6 million, compared to an EBITDA loss of $2.2 million in Q4 2010.

Backlog at December 31, 2011 was $51.5 million, compared to $50.8 million at September 30, 2011 and $55.9 million at December 31, 2010. At December 31, 2011, approximately $5.8 million of GSE’s backlog was related to the Slovakia project. The Company believes that approximately $34.0 million of backlog at December 31, 2011 will convert to revenue in 2012. Not included in backlog at December 31, 2011 is approximately $8.0 million of new orders announced during Q1 2012.

SHARE REPURCHASE

Under the provisions of the share repurchase program authorized by GSE’s Board of Directors in March 2011, during the three and twelve month periods ended December 31, 2011, GSE repurchased 302,974 and 824,374 shares of common stock, respectively, for an aggregate purchase price of $0.5 million and $1.6 million, respectively. Subsequent to the close of the fourth quarter and through March 6, 2012, GSE repurchased an additional 150,287 shares of its common stock for an aggregate purchase price of $0.3 million.

CONFERENCE CALL

Management will host a conference call this afternoon at 4:30 pm Eastern Time to discuss the results. Interested parties may participate in the call by dialing:

  • (877) 407-9753 (Domestic) or
  • (201) 493-6739 (International)

The conference call will also be accessible via the following link:

http://www.investorcalendar.com/IC/CEPage.asp?ID=167551

ABOUT GSE SYSTEMS, INC.

GSE Systems, Inc. provides a wide range of simulation and training solutions to the global energy (nuclear and non-nuclear) industry, and is the world leader in nuclear simulation. The Company has over four decades of experience, more than 1,000 installations, and hundreds of customers in over 50 countries spanning the globe. Our software, hardware and integrated training solutions leverage proven technologies to deliver real-world business advantages to the energy, process, manufacturing and government sectors worldwide. GSE Systems is headquartered in Sykesville (Baltimore), Maryland, with offices in St. Marys, Georgia; Tarrytown, New York; Madison, New Jersey; Cary, North Carolina; Chennai, India; Nyköping, Sweden; Stockton-on-Tees, UK; and Beijing, China. Information about GSE Systems is available via the Internet at http://www.gses.com.

FORWARD LOOKING STATEMENTS

We make statements in this press release that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These statements reflect our current expectations concerning future events and results. We use words such as “expect,” “intend,” “believe,” “may,” “will,” “should,” “could,” “anticipates,” and similar expressions to identify forward-looking statements, but their absence does not mean a statement is not forward-looking. These statements are not guarantees of our future performance and are subject to risks, uncertainties, and other important factors that could cause our actual performance or achievements to be materially different from those we project. For a full discussion of these risks, uncertainties, and factors, we encourage you to read our documents on file with the Securities and Exchange Commission, including those set forth in our periodic reports under the forward-looking statements and risk factors sections. We do not intend to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

GSE SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
Three Months ended Year ended
December 31, December 31,
2011 2010 2011 2010
Contract revenue $ 14,998 $ 12,328 $ 51,126 $ 47,213
Cost of revenue 10,503 10,390 34,781 36,081
Gross profit 4,495 1,938 16,345 11,132
Selling, general and administrative 2,752 3,846 12,672 11,683
Depreciation 132 161 497 579
Amortization of definited-lived intangible assets 319 39 948 102
Operating expenses 3,203 4,046 14,117 12,364
Operating income (loss) 1,292 (2,108 ) 2,228 (1,232 )
Interest income (expense), net 40 (29 ) 131 19
Loss on derivative instruments (117 ) (282 ) (68 ) (913 )
Other income, net 2 18 72 83
Income (loss) before income taxes 1,217 (2,401 ) 2,363 (2,043 )
Provision (benefit) for income taxes 43 119 (438 ) 206
Net income (loss) $ 1,174 $ (2,520 ) $ 2,801 $ (2,249 )
Basic income (loss) per common share $ 0.06 $ (0.13 ) $ 0.15 $ (0.12 )
Diluted income (loss) per common share $ 0.06 $ (0.13 ) $ 0.15 $ (0.12 )
Weighted average shares outstanding – Basic 18,518,687 19,155,782 18,952,401 18,975,007
Weighted average shares outstanding – Diluted 18,569,210 19,155,782 19,122,903 18,975,007
GSE SYSTEMS, INC AND SUBSIDIARIES
Selected balance sheet data
(in thousands)
December 31,
2011
December 31,
2010
Cash and cash equivalents $ 20,326 $ 26,577
Restricted cash- current 3,505 179
Current assets 47,920 45,949
Long-term restricted cash 897 794
Total assets 58,815 53,614
Current liabilities $ 17,680 $ 15,909
Long-term liabilities 2,352 799
Stockholders’ equity 38,783 36,906

EBITDA Reconciliation

EBITDA is not a measure of financial performance under generally accepted accounting principles (“GAAP”). Management believes EBITDA, in addition to operating profit, net income and other GAAP measures, is useful to investors to evaluate the Company’s results because it excludes certain items that are not directly related to the Company’s core operating performance. Investors should recognize that EBITDA might not be comparable to similarly-titled measures of other companies. This measure should be considered in addition to, and not as a substitute for or superior to, any measure of performance prepared in accordance with GAAP. A reconciliation of EBITDA to the most directly comparable GAAP measure in accordance with SEC Regulation G follows:

(in thousands) Three Months Ended December 31, Years Ended December 31,
2011 2010 2011 2010
Net income (loss) $ 1,174 $ (2,520 ) $ 2,801 $ (2,249 )
Interest (income) expense, net (40 ) 29 (131 ) (19 )
Provision (benefit) for income taxes 43 119 (438 ) 206
Depreciation and amortization 451 200 1,445 681
EBITDA $ 1,628 $ (2,172 ) $ 3,677 $ (1,381 )
Thursday, March 8th, 2012 Uncategorized Comments Off on GSE Systems (GVP) Announces 2011 Fourth Quarter and Full Year Financial Results

Inovio Therapeutic (INO) Vaccine Induces Robust T-Cell Immune Response in Mice

BLUE BELL, Pa., March 5, 2012 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO) announced today that its SynCon® therapeutic vaccine for human papillomavirus (HPV) types 6 and 11, which are associated with head & neck cancers and genital warts, among other conditions, induced strong antigen-specific CD8+ T cells in mice. This vaccine is complementary to Inovio’s VGX-3100, a therapeutic vaccine targeting cervical dysplasias and cancers caused by HPV types 16 and 18, which is in a phase II clinical study for CIN 2/3. This positive animal data mirrors the similarly robust T-cell responses induced by VGX-3100 in earlier mice studies. These results were reported in a peer-reviewed paper titled, “Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen,” which has been published in Human Vaccines & Immunotherapeutics.

Dr. J. Joseph Kim, President and CEO, said, “Over a dozen HPV types are recognized as causing cancers and other diseases, with a significant health need and business opportunity for therapeutic vaccines to address these conditions. With the best-in-class T-cell responses generated by VGX-3100 in early human studies, our goal is to create a family of therapeutic vaccines targeting most significant diseases caused by HPV infection, including cervical cancer and dysplasia, vulvar dysplasia, head and neck cancer, and other cancers. This study demonstrates our ability to readily extend our therapeutic solutions to diseases caused by different HPV types. Importantly, our clinical experience with VGX-3100 may also help streamline the regulatory path for these related vaccines.”

HPV types 6 and 11 are the major cause of recurrent respiratory papillomatosis and genital warts. They are also associated with otolaryngologic (ear, nose, and throat) malignancies, carcinoma of the lung, tonsil, larynx, and low-grade cervical lesions.

Similar to Inovio’s VGX-3100, two novel engineered DNA vaccines were developed to target the antigens E6 and E7 of HPV 6 and HPV 11. After designing consensus sequences of these antigens with the purpose of providing broader cross-strain therapeutic effects, the vaccines were also modified to increase gene expression and production of the antigenic protein. These vaccines were delivered using Inovio’s proprietary electroporation delivery system. Together such highly optimized SynCon® vaccines delivered using electroporation have achieved best-in-class immune responses targeting cervical dysplasia and HIV. This study revealed that robust T cell immune responses (especially the important CD8+ T cells) were generated by the HPV 6 and 11 vaccine, as measured by the standard ELISpot assay.

About Inovio Pharmaceuticals, Inc.

Inovio is revolutionizing vaccines to prevent and treat today’s cancers and challenging infectious diseases. Its SynCon® vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio’s proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile. Inovio’s clinical programs include Phase II studies for cervical dysplasia, leukemia and hepatitis C virus and Phase I studies for influenza and HIV. Partners and collaborators include the University of Pennsylvania, Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, US Dept. of Homeland Security and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

* * *

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company’s technology by potential corporate or other partners or collaborators, capital market conditions, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2011, and other regulatory filings from time to time. There can be no assurance that any product in Inovio’s pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACTS:
Investors: Bernie Hertel, Inovio Pharmaceuticals, 858-410-3101
Media: Jeff Richardson, Richardson & Associates, 805-491-8313

(Logo: http://photos.prnewswire.com/prnh/20120131/LA44118LOGO)

SOURCE Inovio Pharmaceuticals, Inc.

Monday, March 5th, 2012 Uncategorized Comments Off on Inovio Therapeutic (INO) Vaccine Induces Robust T-Cell Immune Response in Mice

Gastar Exploration Ltd. (GST) Declares Monthly Cash Dividend

HOUSTON, March 5, 2012 /PRNewswire/ — Gastar Exploration Ltd. (NYSE Amex: GST) (the “Company”) announced today that Gastar Exploration USA, Inc., the wholly-owned subsidiary of the Company, has declared a monthly cash dividend on its 8.625% Series A Preferred Stock (“Series A Preferred Stock”) for March 2012.

The dividend on the Series A Preferred Stock is payable on April 2, 2012 to holders of record at the close of business on March 15, 2012. The March 2012 dividend payment will be an annualized 8.625% per share, which is equivalent to $0.179688 per share, based on the $25.00 per share liquidation preference of the Series A Preferred Stock. The Series A Preferred Stock is currently listed on the NYSE Amex and trades under the ticker symbol “GST.PRA.”

About Gastar Exploration

Gastar Exploration Ltd. is an independent company engaged in the exploration, development and production of natural gas and oil in the United States. Our principal business activities include the identification, acquisition, and subsequent exploration and development of natural gas and oil properties with an emphasis on prospective deep structures identified through seismic and other analytical techniques as well as unconventional natural gas reserves, such as shale resource plays. We are pursuing natural gas exploration in the Marcellus Shale in the Appalachian area of West Virginia and central and southwestern Pennsylvania and in the deep Bossier gas play in the Hilltop area of East Texas. We also conduct limited coal bed methane development activities within the Powder River Basin of Wyoming and Montana. For more information, visit our web site at www.gastar.com.

Safe Harbor Statement and Disclaimer

This news release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. A statement identified by the words “expects,” “projects,” “plans,” and certain of the other foregoing statements may be deemed forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, these statements involve risks and uncertainties that may cause actual future activities and results to be materially different from those suggested or described in this news release.

Contacts:
Gastar Exploration Ltd.
J. Russell Porter, Chief Executive Officer
713-739-1800 / rporter@gastar.com

Investor Relations Counsel:
Lisa Elliott / Anne Pearson
DRG&L: 713-529-6600
lelliott@drg-l.com / apearson@drg-l.com

Monday, March 5th, 2012 Uncategorized Comments Off on Gastar Exploration Ltd. (GST) Declares Monthly Cash Dividend

VistaGen Therapeutics (VSTA) and Duke University Enter Into Strategic Research Collaboration

SOUTH SAN FRANCISCO, CA — (Marketwire) — 03/05/12 — VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, and Duke University, one of the country’s premier academic research institutions, have entered into a strategic research collaboration aimed at combining their complementary expertise at the forefront of cardiac stem cell technology, electrophysiology and tissue engineering. The initial goal of the collaboration is to explore potential development of novel, engineered, stem cell-derived cardiac tissues to expand the scope of VistaGen’s drug rescue capabilities focused on heart toxicity. The research will be led at Duke, by Dr. Nenad Bursac, Associate Professor in the Departments of Cardiology and Biomedical Engineering, and at VistaGen, by Dr. Ralph Snodgrass, President and Chief Scientific Officer.

“We are pleased to be collaborating with Dr. Bursac and his team at Duke,” said Dr. Snodgrass. “Our human stem cell-derived heart cells combined with Dr. Bursac’s cutting-edge technology relating to cardiac electrophysiology and cardiac tissue engineering will permit us to use micro-patterned cardiac tissue to significantly expand the approaches we use in our Drug Rescue Programs to quantify drug effects on functional human cardiac tissue — in effect, synthetic human heart muscle.”

Dr. Bursac is a leader in the field of cardiac tissue engineering and cell-based therapies in which different cells, either alone or in combination with therapeutic molecules or biomaterials, can be transplanted into the human body to restore function of damaged or diseased organs. Dr. Bursac’s research has additional applications in the fields of cardiac electrophysiology, in vitro drug screening, and the generation of novel bioengineered model systems for studies of heart development, function, and disease.

About VistaGen Therapeutics

VistaGen is a biotechnology company applying human pluripotent stem cell technology for drug rescue and cell therapy. VistaGen’s drug rescue activities combine its human pluripotent stem cell technology platform, Human Clinical Trials in a Test Tube™, with modern medicinal chemistry to generate new chemical variants (Drug Rescue Variants) of once-promising small-molecule drug candidates. These are drug candidates discontinued by pharmaceutical companies, the U.S. National Institutes of Health (NIH) or university laboratories after substantial development due to heart toxicity. VistaGen uses its pluripotent stem cell technology to generate early indications, or predictions, of how humans will ultimately respond to new drug candidates before they are ever tested in humans, bringing human biology to the front end of the drug development process.

Additionally, VistaGen’s small molecule drug candidate, AV-101, is in Phase 1b development for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S. alone. VistaGen is also exploring opportunities to leverage its current Phase 1 clinical program to enable additional Phase 2 clinical studies of AV-101 for epilepsy, Parkinson’s disease and depression. To date, VistaGen has been awarded over $8.5 million from the NIH for development of AV-101.

Visit VistaGen at http://www.VistaGen.com, follow VistaGen at http://www.twitter.com/VistaGen or view VistaGen’s Facebook page at http://www.facebook.com/VistaGen.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to the success of VistaGen’s stem cell technology-based drug rescue activities, ongoing AV-101 clinical studies, its ability to enter into drug rescue collaborations and/or licensing arrangements with respect to one or more drug rescue variants, risks and uncertainties relating to the availability of substantial additional capital to support VistaGen’s research, drug rescue, development and commercialization activities, and the success of its research and development plans and strategies, including those plans and strategies related to AV-101 and any drug rescue variant identified and developed by VistaGen. These and other risks and uncertainties are identified and described in more detail in VistaGen’s filings with the Securities and Exchange Commission (SEC). These filings are available on the SEC’s website at www.sec.gov. VistaGen undertakes no obligation to publicly update or revise any forward-looking statements.

For More Information:

Shawn K. Singh, J.D.
Chief Executive Officer
VistaGen Therapeutics, Inc.
www.VistaGen.com
650-244-9990 x224
Investor.Relations@VistaGen.com

Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975
Investors@MissionIR.com

Monday, March 5th, 2012 Uncategorized Comments Off on VistaGen Therapeutics (VSTA) and Duke University Enter Into Strategic Research Collaboration

Zalicus (ZLCS) Successfully Completes Phase 1 Clinical Study with Reformulated Z160

Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the successful completion of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of a new formulation of Z160, a novel oral N-type calcium channel blocker. In the study, Z160 demonstrated substantial bioavailability and solubility improvements using a novel, proprietary formulation technology. Based on the data from this study, Zalicus plans to advance Z160 into Phase 2 clinical development for the treatment of neuropathic pain in the second half of 2012. A previous formulation of Z160 was studied in clinical trials of over 200 subjects and was well tolerated.

“We are encouraged by the substantial bioavailability and solubility improvements achieved with the new formulation of Z160 tested in this study,” commented Mark H.N. Corrigan, MD, President and CEO of Zalicus. “These data provides us with the confidence that we can achieve appropriate and consistent exposure levels to evaluate Z160’s efficacy in pain and we look forward to beginning a Phase 2 clinical study in neuropathic pain in the second half of 2012.”

About Z160 and N-type Calcium Channel Blockers:

Z160 is a novel oral N-type calcium channel blocker that has shown efficacy in multiple animal models of neuropathic and inflammatory pain, has been well tolerated in Phase 1 and Phase 2a clinical trials in approximately 200 subjects and has been reformulated to address prior bioavailability and food effect issues. N- type calcium channels have been recognized as key targets in the therapeutic inhibition of a broad range of cell functions. Specifically for pain indications, these calcium channels have been recognized as critical for controlling the entry of calcium into neurons. When a pain signal is initiated, calcium channels open and calcium concentration increases, triggering the release of neurotransmitters to the brain where it is perceived as pain and also increasing the general excitability of neurons resulting in the amplification of pain signals. Zalicus has utilized its expertise in this field to successfully discover high affinity, selective and orally available compounds such as Z160 that block N- type calcium channels and that show promise for further development as therapies for pain. Zalicus plans to advance a proprietary formulation of its lead N-type calcium channel product candidate, Z160, into Phase 2 clinical development for neuropathic pain in the second half of 2012.

About Zalicus

Zalicus Inc. (Nasdaq: ZLCS) is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Zalicus has a portfolio of proprietary clinical-stage product candidates targeting pain and immuno-inflammatory diseases and have entered into multiple revenue-generating collaborations with large pharmaceutical companies relating to other products, product candidates and drug discovery technologies. Zalicus applies its expertise in the discovery and development of selective ion channel modulators and its combination high throughput screening capabilities to discover innovative therapeutics for itself and its collaborators in the areas of pain, inflammation, oncology and infectious disease.

To learn more about Zalicus, please visit www.zalicus.com.

Forward-Looking Statement:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning Zalicus, its product candidate Z160, its potential and the plans for its clinical development, the Zalicus selective ion channel modulation technology, and related preclinical product candidates, Zalicus’ combination drug discovery technology, cHTS, and its other business plans. These forward-looking statements about future expectations, plans, objectives and prospects of Zalicus may be identified by words like “believe,” “expect,” “may,” “will,” “should,” “seek,” “plan” or “could” and similar expressions and involve significant risks, uncertainties and assumptions, including risks related to the development and regulatory approval of Zalicus’ product candidates, risks relating to formulation and clinical development of Z160, the unproven nature of the Zalicus drug discovery technologies, the ability of the Company to initiate and successfully complete clinical trials of its product candidates, the Company’s ability to obtain additional financing or funding for its research and development and those other risks that can be found in the “Risk Factors” section of Zalicus’ annual report on Form 10-K on file with the Securities and Exchange Commission and the other reports that Zalicus periodically files with the Securities and Exchange Commission. Actual results may differ materially from those Zalicus contemplated by these forward-looking statements. These forward-looking statements reflect management’s current views and Zalicus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this release except as required by law.

(c) 2012 Zalicus Inc. All rights reserved.

Monday, March 5th, 2012 Uncategorized Comments Off on Zalicus (ZLCS) Successfully Completes Phase 1 Clinical Study with Reformulated Z160

Category I Code Approved for TranS1’s (TSON) AxiaLIF Pre-Sacral Interbody Fusion

WILMINGTON, N.C., March 5, 2012 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat degenerative conditions of the spine affecting the lower lumbar region, announced today that the American Medical Association (“AMA”) Current Procedural Terminology (“CPT”) Panel has voted to approve an application for a Category I CPT code for L5-S1 spinal fusion utilizing TranS1’s pre-sacral interbody fusion approach with its AxiaLIF® implant. This coding change was recently disclosed on the AMA website and will become effective on January 1, 2013.

“This is a significant achievement and an endorsement of the maturation of pre-sacral interbody fusion as a minimally invasive solution at L5-S1,” stated Ken Reali, TranS1’s President and CEO. “The body of peer-reviewed clinical literature that has been published supported the Category I code that was approved.”

The Company will provide further information during its fourth quarter 2011 results conference call on March 8, 2012.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single and two level lumbar fusion, the VEO™ lateral access and interbody fusion system, and the Vectre™ and Avatar™ posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.

CONTACT: Investors:
         TranS1 Inc.
         Joseph P. Slattery, 910-332-1700
         Executive Vice-President and Chief Financial Officer

         Westwicke Partners
         Mark Klausner, 443-213-0501
         trans1@westwicke.com
Monday, March 5th, 2012 Uncategorized Comments Off on Category I Code Approved for TranS1’s (TSON) AxiaLIF Pre-Sacral Interbody Fusion

Star Scientific (CIGX) Announces Notice of Allowance by US PTO Granting New Patent Claims

GLEN ALLEN, Va., March 1, 2012 /PRNewswire/ — Star Scientific, Inc. (NASDAQ: CIGX) announced that the US Patent & Trademark Office (USPTO) issued a Notice of Allowance on February 16, 2012 in Application No. 12/342,192 by Jonnie Williams, entitled “Tobacco Curing Method”, formally granting patent claims for a new method of curing tobacco. The written patent will issue from the USPTO within the next several months. The ‘192 application discloses the minimizing of TSNA (tobacco-specific nitrosamine) formation in tobacco by subjecting it to a controlled environment while a majority of the leaf is in a green, uncured state. The process, therefore, represents an improvement over the method described in the Williams ‘649 patent; Star Scientific believes it is particularly well-suited for curing tobacco for use in smokeless tobacco products.

(Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO )

“The significance of the decision by the USPTO to grant these novel claims cannot be overstated,” said Paul L Perito, Esq, Chairman, President and Chief Operating Officer of Star Scientific. “The new tobacco curing technology developed by Mr. Williams now makes it possible to reduce the levels of a class of known carcinogenic toxins in cured tobacco to nearly undetectable levels. We believe that the 2009 Tobacco Control Act requirement that tobacco companies list the harmful constituents in their products, when implemented, may encourage those companies to reduce toxins where the technology for those reductions is available.”

The Center for Tobacco Products at the FDA, as mandated by the 2009 Tobacco Act, is required to publish a list of harmful and potentially harmful compounds, and the levels of each compound by tobacco product brand offerings. The stated purpose of this initiative is to inform and educate the public about the range and scope of harmful and potentially harmful elements in tobacco products. The FDA in December 2011 published a request for comments on a study it is conducting to identify the most effective means of communicating this information to the public. Therefore, that list has not been finalized; however, TSNAs were unanimously identified by the Tobacco Product Scientific Advisory Subcommittee for inclusion in the list at the beginning of this process. The company believes that when the list becomes public, it should allow adult tobacco users to identify differences in the toxin levels, including TSNAs, contained in various tobacco products. TSNAs were first identified approximately fifty years ago as one of the most lethal and abundant groups of toxins in tobacco leaf and smoke.

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “projects” and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical and low-TSNA tobacco products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, including with respect to our nutraceutical and low-TSNA tobacco products, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended December 31, 2010. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.

About Star Scientific
Star Scientific is a technology-oriented company with a mission to reduce the harm associated with tobacco at every level. It is engaged in the development of dissolvable smokeless tobacco products that deliver fewer carcinogenic toxins, principally through the utilization of the innovative StarCured® tobacco curing technology. Its subsidiary, Rock Creek Pharmaceuticals, Inc., is involved in the development of nutraceuticals as well as products to address neurological and mood disorders. Rock Creek Pharmaceuticals has scientific and research offices in Gloucester, MA, and a regulatory office in Washington, D.C. Star Scientific has a Corporate and Sales Office in Glen Allen, VA, an Executive, Scientific & Regulatory Affairs office in Bethesda, MD, and a manufacturing facility in Chase City, VA.

Contact:
Sara Troy Machir
Vice President, Communications & Investor Relations
(301) 654-8300

SOURCE Star Scientific, Inc.

Thursday, March 1st, 2012 Uncategorized Comments Off on Star Scientific (CIGX) Announces Notice of Allowance by US PTO Granting New Patent Claims

The Bon-Ton Stores, Inc. (BONT) Announces February Sales

The Bon-Ton Stores, Inc. (NASDAQ: BONT) today announced comparable store sales for the four weeks ended February 25, 2012 increased 0.7%. Total sales increased 0.9% to $199.4 million for the four weeks compared with $197.7 million for the prior year period.

Tony Buccina, Vice Chairman, President – Merchandising, commented, “We are pleased with our February sales results. Our best performing businesses were shoes; hard home; furniture; ladies’ better sportswear; and cosmetics, especially in fragrances, which did very well for Valentine’s Day. Favorable customer response to bright, bold colors in ladies’ shoes and handbags resulted in strong sales. The poorest performing category was coats. We successfully moved through product and are pleased with our inventory position at the end of February. As a reminder, last year’s February sales included Community Day, which is an important promotional event for our Company and our communities; this year the event will occur in April.”

Keith Plowman, Executive Vice President and Chief Financial Officer, stated, “Our excess borrowing capacity under our credit facility was approximately $453 million at the end of February.”

The Bon-Ton Stores, Inc., with corporate headquarters in York, Pennsylvania and Milwaukee, Wisconsin, operates 272 department stores, which includes 11 furniture galleries, in 23 states in the Northeast, Midwest and upper Great Plains under the Bon-Ton, Bergner’s, Boston Store, Carson Pirie Scott, Elder-Beerman, Herberger’s and Younkers nameplates and, in the Detroit, Michigan area, under the Parisian nameplate. The department stores offer a broad assortment of national and private brand fashion apparel and accessories for women, men and children, as well as cosmetics and home furnishings. For further information, please visit the investor relations section of the Company’s website at http://investors.bonton.com.

Certain information included in this press release contains statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, which may be identified by words such as “may,” “could,” “will,” “plan,” “expect,” “anticipate,” “estimate,” “project,” “intend” or other similar expressions, involve important risks and uncertainties that could significantly affect results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of the Company. Factors that could cause such differences include, but are not limited to, risks related to retail businesses generally; a significant and prolonged deterioration of general economic conditions which could negatively impact the Company, including the potential write-down of the current valuation of intangible assets and deferred taxes; changes in the terms of the Company’s proprietary credit card program; potential increase in pension obligations; consumer spending patterns, debt levels, and the availability and cost of consumer credit; additional competition from existing and new competitors; inflation; deflation; changes in the costs of fuel and other energy and transportation costs; weather conditions that could negatively impact sales; uncertainties associated with expanding or remodeling existing stores; the ability to attract and retain qualified management; the dependence upon relationships with vendors and their factors; a data security breach or system failure; the ability to reduce or control SG&A expenses; the incurrence of unplanned capital expenditures; the ability to obtain financing for working capital, capital expenditures and general corporate purpose; the impact of new regulatory requirements including the Credit Card Accountability Responsibility and Disclosure Act of 2009 and the Health Care Reform Act; the inability or limitations on the Company’s ability to favorably adjust the valuation allowance on deferred tax assets; the financial condition of mall operators; the successful transition of the position of chief executive officer from Mr. Bergren to Mr. Hoffman. Additional factors that could cause the Company’s actual results to differ from those contained in these forward-looking statements are discussed in greater detail under Item 1A of the Company’s Form 10-K filed with the Securities and Exchange Commission.

Thursday, March 1st, 2012 Uncategorized Comments Off on The Bon-Ton Stores, Inc. (BONT) Announces February Sales

Al Angrisani to Serve as President and Chief Executive Officer of Harris Interactive (HPOL)

NEW YORK, March 1, 2012 /PRNewswire/ — Harris Interactive Inc. (Nasdaq: HPOL), a global custom market research firm, today announced that Al Angrisani will serve as its President and Chief Executive Officer, and will join the Board of Directors of the Company, as Vice Chairman, effective immediately. Mr. Angrisani has served as the Company’s Interim Chief Executive Officer since June 7, 2011.

(Logo: http://photos.prnewswire.com/prnh/20100518/NY06801LOGO)

Mr. Angrisani commented, “Since last June we have made progress initiating the turnaround program and improving the Company’s cash and liquidity position. Much work needs to be done, but my decision to serve as President and CEO demonstrates my strong belief in Harris and the Harris brand. I look forward to working with the management team, employees, and the Board of Directors to improve shareholder value through the execution of a successful turnaround program.”

Howard Shecter, Chairman of Harris Interactive’s Board of Directors, said, “I am pleased that Al has agreed to become President and CEO of the Company through June 30, 2014. Al’s leadership has already had a tremendous impact on the Company and is critical to our ability to successfully execute the turnaround program.”

Additional details regarding Mr. Angrisani’s appointments can be found in the Company’s Current Report on Form 8-K filed today with the Securities and Exchange Commission.

Cautionary Note Regarding Forward Looking Statements

Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, among others, statements as to future economic performance, projections as to financial items, estimates, and plans and objectives for future operations, products and services. In some cases, you can identify forward-looking statements by terminology such as, “may”, “should”, “expects”, “plans”, “anticipates”, “feel”, “believes”, “estimates”, “predicts”, “potential”, “continue”, “consider”, “possibility”, or the negative of these terms or other comparable terminology. These forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward looking statements. Such risks and uncertainties include, without limitation, risks detailed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K, as updated quarterly in our Quarterly Reports on Form 10-Q to reflect additional material risks. The Company has filed its reports on Forms 10-K and 10-Q with the Securities and Exchange Commission, and they are available under the Investor Relations section of our website at http://ir.harrisinteractive.com/. Risks and uncertainties also include the continued volatility of the global macroeconomic environment and its impact on the Company and its clients, the Company’s ability to sustain and grow its revenue base, the Company’s ability to maintain and improve cost efficient operations, the impact of reorganization, restructuring and related charges, quarterly variations in financial results, actions of competitors, the Company’s ability to develop and maintain products and services attractive to the market, the Company’s ability to remain in compliance with the financial covenants in its credit agreement, and uncertainties surrounding the Company’s ability to regain compliance with certain NASDAQ listing requirements.

You are urged to consider these factors carefully in evaluating such forward-looking statements and are cautioned not to place undue reliance on them. The forward-looking statements are qualified in their entirety by this cautionary statement.

About Harris Interactive
Harris Interactive is one of the world’s leading custom market research firms, leveraging research, technology, and business acumen to transform relevant insight into actionable foresight. Known widely for the Harris Poll and for pioneering innovative research methodologies, Harris offers expertise in a wide range of industries including health care, technology, public affairs, energy, telecommunications, financial services, insurance, media, retail, restaurant, and consumer package goods. Serving clients in more than 215 countries and territories through our North American and European offices and a network of independent market research firms, Harris specializes in delivering research solutions that help us – and our clients – stay ahead of what’s next. For more information, please visit www.harrisinteractive.com.

HPOL – F

Press Contact:

Michael T. Burns
Investor Relations
Harris Interactive Inc.
800-866-7655 x7328
mburns@harrisinteractive.com

SOURCE Harris Interactive

Thursday, March 1st, 2012 Uncategorized Comments Off on Al Angrisani to Serve as President and Chief Executive Officer of Harris Interactive (HPOL)

Sky-mobi (MOBI) to Provide Content and Service Cooperation to China Mobile Group’s Mobile Gaming Platform

HANGZHOU, China, March 1, 2012 (GLOBE NEWSWIRE) — Sky-mobi Limited (“Sky-mobi” or the “Company”) (Nasdaq:MOBI), a leading mobile application store and mobile social network community operator in China, today announced that its subsidiary, Hangzhou Mijia Technologies Co., Ltd., has entered into a partnership agreement with China Mobile Group Jiangsu Company Limited (“Jiangsu Mobile”), a wholly-owned subsidiary of China Mobile Group, to provide content and operational cooperation for China Mobile’s gaming platform nationwide.

Under the terms of the one-year agreement, Sky-mobi will provide cooperative content, including single user games and applications, online multi-player games and other content, on China Mobile Group’s gaming platform along with customer service and operation cooperation for the games and content for feature phones. Jiangsu Mobile is responsible for development and maintenance of the gaming platform, new game screening, launches and related gaming channel operations, including collections. Jiangsu Mobile will share revenue with Sky-mobi based on paid downloads and usage. Over the course of the agreement both parties will work together on marketing, promotions and user development.

Mr. Michael Song, Chairman and Chief Executive Officer of Sky-mobi, stated, “We are pleased to partner with China Mobile to provide content and operational cooperation for its mobile gaming platform. China Mobile Group is the leading mobile service provider in China and our cooperation will further enhance our industry presence and increase confidence amongst our subscribers. Through this arrangement, high quality games will be available to 80% of our Maopao users throughout China. We expect this partnership will provide both parties with operational and financial benefits going forward.”

About Sky-mobi Limited

Sky-mobi Limited operates the leading mobile application store in China as measured by revenues in 2010, according to Analysys International. The company works with handset companies to pre-install its Maopao mobile application store on handsets and with content providers to provide users with applications and content titles. Users of its Maopao store can browse, download, and enjoy a range of applications and content, such as single-player games, mobile music, and books. The Company’s Maopao store enables mobile applications and content to be downloaded and run on various mobile handsets with different hardware and operating system configurations. The company also operates a mobile social network community in China, the Maopao Community, where it offers mobile social games, as well as applications and content with social network functions to its registered members. The Company is based in Hangzhou, the People’s Republic of China. For more information, please visit: www.sky-mobi.com.

The Sky-mobi Limited logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8458

About China Mobile Group

As the leading mobile services provider in China, China Mobile Group boasts the world’s largest mobile network and the world’s largest mobile customer base. As of 31 December 2010, the Group had a total staff of 164,336 and a customer base of 584 million, and enjoyed a market share of approximately 69.3% in Mainland China. The Group’s GSM global roaming services covered 237 countries and regions and its GPRS roaming services covered 186 countries and regions. The Company owns 100% interest in operating subsidiaries in 31 provinces in Mainland China and in Hong Kong.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as ”believes,” ”expects,” ”anticipates,” ”intends,” ”estimates,” the negative of these terms, or other comparable terminology. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Potential risks and uncertainties include the effectiveness, profitability, and marketability of the Company’s solutions; the Company’s limited operating history; measures introduced by the PRC government and mobile network operators aimed at the telecommunications industry and mobile applications-related services; the Company’s ability to maintain cooperation relationships with handset companies, content providers and payment service providers; its dependence on mobile service providers, and ultimately mobile network operators, for the collection of a substantial majority of its revenues; billing and transmission failures, which are often beyond the Company’s control; its ability to compete effectively; its ability to capture opportunities in the expected growth of the smart phone market; its ability to obtain and maintain all applicable permits and approvals; general economic and business conditions; the volatility of the Company’s operating results and financial condition; the Company’s ability to attract or retain qualified senior management personnel and research and development staff; and other risks detailed in the Company’s filings with the Securities and Exchange Commission. These forward-looking statements are based on current expectations, assumptions, estimates and projections about the Company and the industry. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.

CONTACT: Sky-mobi Limited
         Mr. Carl Yeung, CFO
         Phone: +(86) 571-87770978 (Hangzhou)
         Email: ir@sky-mobi.com

         CCG Investor Relations
         Elaine Ketchmere, Partner and VP
         Phone: +(1) 310-954-1345 (Los Angeles)
         Email: elaine.ketchmere@ccgir.com
Thursday, March 1st, 2012 Uncategorized Comments Off on Sky-mobi (MOBI) to Provide Content and Service Cooperation to China Mobile Group’s Mobile Gaming Platform

Sino Clean Energy, Inc. (SCEI) Announces Asset and Cash Verification Results

XI’AN, China, March 1, 2012 /PRNewswire-Asia-FirstCall/ — Sino Clean Energy Inc. (NASDAQ: SCEI) (“Sino Clean Energy,” or the “Company”), a leading producer and distributor of coal-water slurry fuel (“CWSF”) in China, today announced that Thornhill Capital LLC (“Thornhill”) recently completed its Asset and Cash Verification Reports for the Audit Committee of the Company.

As previously noted, the Audit Committee engaged Thornhill, an independent third-party evaluation agency, to conduct certain analyses to assist the Audit Committee and its professionals to investigate allegations made by short sellers. Last November, the Company announced Thornhill’s reconciliation of the Company’s tax returns filed with the State Administration of Taxation (SAT) and its filings with the State Administration of Industry and Commerce (SAIC) against audited financial information filed with US Securities and Exchange Commission under US GAAP. Since that time, the Audit Committee requested Thornhill to do additional work, and provide additional reports, regarding verification of fixed assets and cash. Thornhill has now completed its analysis and provided its reports on these two additional matters.

With regard to verification of fixed assets, Thornhill based its conclusions on a review of relevant original purchase, bank, and accounting documentation regarding the Company’s fixed assets and a physical viewing of the facilities’ assets. As a result, and based on the scope of its verification, Thornhill concluded in its report dated January 2, 2012 that it is unlikely that the Company’s fixed asset balances as described in the Company’s Form 10-K as of December 31, 2010, and Form 10-Q as of September 30, 2011, are materially misstated.

With regard to verification of the Company’s cash balance Thornhill undertook to make its verifications at December 31 2011 and January 18, 2012 (the date on which it conducted the verification), Thornhill, in its report dated February 1, 2012, reported that it was able to verify over 95% of the Company’s consolidated cash balance as of December 31, 2011, and January 18, 2012, respectively. These verifications were based on bank statements obtained directly by Thornhill staff from the relevant banks on January 18 2012 and confirmed and reconciled to the Company’s December 31, 2011 cash balance.

Baowen Ren, chairman and chief executive officer of Sino Clean Energy, commented, “We welcome the internal investigation being conducted by the Audit Committee generally and, specifically, the completion of Thornhill’s verifications. These positive reports should adequately address any reasonable concerns raised about the Company’s credibility and profitability in the pertinent areas and help put the short sellers’ claims in proper perspective. We look forward to providing other updates at the Company’s next earnings call.”

About Sino Clean Energy

Sino Clean Energy is the third largest producer of coal-water slurry fuel (“CWSF”) by sales in China, according to data provided in Frost & Sullivan’s 2010 Chinese CWSF market report. A leader in developing CWSF as a cleaner alternative to burning coal aggregate in heating, industrial and power generation for residential and industrial applications, the Company has seven production lines located in Shaanxi, Liaoning, and Guangdong provinces. For more information about Sino Clean Energy, please visit http://www.sinocei.net.

Contact Information

Sino Clean Energy Inc.
Jing Li, Assistant to the CEO
Phone: +86-29-8844-7960 ext. 802
Email: Jing.Li@sinocei.net

ICR Inc.
Rob Koepp
Phone: +86-10-6583-7516 or +1-646-328-2526
E-mail: SCEI@icrinc.com

SOURCE Sino Clean Energy Inc.

Thursday, March 1st, 2012 Uncategorized Comments Off on Sino Clean Energy, Inc. (SCEI) Announces Asset and Cash Verification Results